• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by Unilever PLC

    2/13/25 11:34:58 AM ET
    $UL
    Package Goods/Cosmetics
    Consumer Discretionary
    Get the next $UL alert in real time by email
    6-K 1 a9248w.htm FINAL RESULTS a9248w
    FORM 6-K
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
     
     
    REPORT OF FOREIGN ISSUER
     
     
    Pursuant to Rule 13a-16 or 15d-16
    of the Securities Exchange Act of 1934
     
     
    Dated February 13, 2025
     
    Commission File Number: 001-04546
     
    UNILEVER PLC
    (Translation of registrant's name into English)
     
    UNILEVER HOUSE, BLACKFRIARS, LONDON, ENGLAND
    (Address of principal executive offices)
     
    Indicate by check mark whether the registrant files or will file annual reports
    under cover Form 20-F or Form 40-F.
     
    Form 20-F..X.. Form 40-F 
     
    Indicate by check mark if the registrant is submitting the Form 6-K in paper
    as permitted by Regulation S-T Rule 101(b)(1):_____
     
    Indicate by check mark if the registrant is submitting the Form 6-K in paper
    as permitted by Regulation S-T Rule 101(b)(7):_____
     
    Indicate by check mark whether the registrant by furnishing the information
    contained in this Form is also thereby furnishing the information to the
    Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
     
    Yes   No .X..
     
    If "Yes" is marked, indicate below the file number assigned to the registrant
    in connection with Rule 12g3-2(b): 82- _______
     
      
    Exhibit 99 attached hereto is incorporated herein by reference.
     

     
     
    Signatures
     
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
     
    UNILEVER PLC
     
    /S/ M VARSELLONA
    BY  M VARSELLONA
    CHIEF LEGAL OFFICER AND GROUP SECRETARY

    Date: 13 February, 2025
     
     
     
                                              EXHIBIT INDEX
                                             ------------------------
     
    EXHIBIT NUMBER
    EXHIBIT DESCRIPTION
    99
    Notice to London Stock Exchange dated 13 February 2025
     
    Final Results
     
     
     
    Exhibit 99
     
     
    2024 Full Year Results
     
    Improved performance led by volume growth and gross margin expansion
     
    Underlying performance
     
     
    GAAP measures
    (unaudited)
                                            2024
                                          vs 2023
     
     
     
                                                2024
                                          vs 2023
    Full Year
     
     
     
     
     
     
     
    Underlying sales growth (USG)
     
     
    4.2%
     
     
     
    Turnover
     
    €60.8bn
     
    1.9%
     
    Beauty & Wellbeing
     
     
    6.5%
     
     
     
    Beauty & Wellbeing
     
    €13.2bn
     
    5.5%
     
    Personal Care
     
     
    5.2%
     
     
     
    Personal Care
     
    €13.6bn
     
    (1.5)%
     
    Home Care
     
     
    2.9%
     
     
     
    Home Care
     
    €12.3bn
     
    1.4%
     
    Foods(a)
     
     
    2.6%
     
     
     
    Foods(a)
     
    €13.4bn
     
    1.1%
     
    Ice Cream
     
     
    3.7%
     
     
     
    Ice Cream
     
    €8.3bn
     
    4.5%
     
    Underlying operating profit
     
    €11.2bn
     
    12.6%
     
     
     
    Operating profit
     
    €9.4bn
     
    (3.7)%
     
    Underlying operating margin
     
    18.4%
     
    170bps
     
     
     
    Operating margin
     
    15.5%
     
    (90)bps
     
    Underlying earnings per share
     
    €2.98
     
    14.7%
     
     
     
    Diluted earnings per share
     
    €2.29
     
    (10.6)%
     
    Free cash flow
     
    €6.9bn
     
    €(0.2)bn
     
     
     
    Net profit
     
    €6.4bn
     
    (10.8)%
     
    Fourth Quarter
     
     
     
     
     
     
     
     
    USG
     
    4.0%
     
     
    Turnover
    €14.2bn
    (0.1)%
    Quarterly dividend payable in March 2025
     
     
    €0.4528
    per share(b)
      (a) Previously reported as Nutrition; (b) See note 9 for more information on dividends
     
    Financial and operational highlights
     
    ●      Underlying sales growth of 4.2%, led by 2.9% volume growth
     
    ●      Turnover increased 1.9% to €60.8 billion with (0.7)% impact from currency and (1.5)% from net disposals
     
    ●      Power Brands (>75% of turnover) leading growth with 5.3% USG and volumes up 3.8%
     
    ●      Brand and marketing investment up 120bps to 15.5%, its highest level in over a decade
     
    ●      Underlying operating margin up 170bps to 18.4%, with gross margin up 280bps
     
    ●      Underlying EPS increased 14.7%; diluted EPS decreased 10.6% due to loss on disposals and accelerated productivity programme spend
     
    ●      Cash conversion of 106% with free cash flow of €6.9 billion; underlying ROIC up 190bps to 18.1%
     
    ●      Quarterly dividend raised by 6.1% vs Q4 2023; new €1.5 billion share buyback announced
     
    ●      Ice Cream separation on track
     
     
    Chief Executive Officer statement
     
    "Today's results reflect a year of significant activity as we focused on transforming Unilever into a consistently higher performing business.
     
    Under the Growth Action Plan, we committed to doing fewer things, better and with greater impact. We executed the plan at pace and made progress in 2024. Underlying sales grew 4.2% with volumes up 2.9%, led by our Power Brands, with particularly strong performances from Dove, Comfort, Vaseline and Liquid I.V. Fewer, bigger innovations helped to deliver volume growth consistently above 2% in each quarter. All Business Groups delivered positive volume growth for the year. Growth was underpinned by gross margin expansion of 280bps, fuelling increases in brand investment and profitability.
     
    We continue to sharpen our portfolio, allocating capital to premium segments by acquiring scalable brands in attractive markets, such as K18 and Minimalist, and announcing the divestment of local food brands such as Unox and Conimex, as we focus our Foods portfolio on cooking aids and condiments categories. The comprehensive productivity programme we announced in March is being implemented at pace and we are ahead of plan in helping to create a leaner and more accountable organisation. We are taking decisive actions in Indonesia, where long-standing challenges required a reset of the business, and China, where we are transforming our go-to-market approach during a market slowdown. We expect to see the benefits of these actions from the second half of 2025.
     
    The separation of Ice Cream remains on track and we are making good progress on the key workstreams. We announce today the appointment of the Chair Designate for the demerged Ice Cream business and details of the listing structure.
     
    Market growth, which slowed throughout 2024, is expected to remain soft in the first half of 2025. The steps we have taken in 2024, including the launch of our refreshed GAP2030 strategy, further reinvestment in our brands and strong innovation pipelines leave us better positioned to deliver on our ambitions in the years ahead."
     
    Hein Schumacher
     
    Outlook
     
    We expect underlying sales growth (USG) for full year 2025 to be within our multi-year range of 3% to 5%. Market growth slowed throughout 2024. We anticipate a slower start to 2025 with subdued market growth in the near term. We expect the market and our growth to improve during the year as price increases, reflecting higher commodity costs in 2025. We expect a more balanced split between volume and price.
     
    We anticipate a modest improvement in underlying operating margin for the full year versus 18.4% in 2024. We expect this improvement to be realised in the second half given the very strong first half comparator of 19.6%, which benefitted strongly from the combination of carry-over pricing and input cost deflation.
     
     
    Full Year Review: Unilever Group
     
     
    (unaudited)
    Turnover
    USG
    UVG
    UPG
    A&D
    Currency
    Turnover
    change
    Full Year
     
    €60.8bn
     
    4.2%
     
    2.9%
     
    1.3%
     
    (1.5)%
     
    (0.7)%
     
    1.9%
     
    Fourth Quarter
    €14.2bn
    4.0%
    2.7%
    1.3%
    (2.9)%
    (1.1)%
    (0.1)%
     
    Performance
     
    Underlying sales growth for the full year was 4.2%, led by volume of 2.9% and price of 1.3%. We delivered four consecutive quarters of underlying volume growth above 2%, with all Business Groups driving positive volume growth for the year. As expected, underlying price growth moderated to 1.3%. Turnover was €60.8 billion, up 1.9% versus the prior year, with underlying sales growth of 4.2% more than offsetting the (0.7)% impact from currency and (1.5)% from disposals net of acquisitions.
     
    The Power Brands contributed >75% of turnover and performed strongly with 5.3% underlying sales growth, driven by volume growth of 3.8%. The rest of the business also delivered improved volumes with volume growth of 0.7% in the second half, up from (1.6)% in the first half of 2024.
     
    As guided with our first half 2024 results, our turnover-weighted market share movement(a), which measures our competitive performance on a rolling 12 month-basis, sequentially improved in the second half reflecting the increasing benefits from the Growth Action Plan.
     
    Beauty & Wellbeing grew underlying sales by 6.5%, with volume growth of 5.1% driven by strong growth across its Power Brands. Personal Care grew 5.2% with 3.1% volume growth, led by strong, innovation-led sales growth of Deodorants. Home Care underlying sales increased 2.9%, with 4.0% volume growth more than offsetting the price decline linked to commodity cost deflation. Foods grew underlying sales 2.6%, with muted volume growth of 0.2% amidst a market slowdown and moderating prices. Ice Cream grew 3.7%, with a return to positive volume growth of 1.6%. This reflected an improved performance in the second half supported by bigger innovations and operational improvements.
     
    Developed markets (42% of Group turnover) grew underlying sales 4.4%. Underlying volume growth of 3.3% reflected a strong performance in North America, led by Beauty & Wellbeing, and a big improvement in Europe, driven by Home Care and Personal Care. As expected, price growth moderated to 1.1%.
     
    Emerging markets (58% of Group turnover) grew underlying sales 4.1%, with 2.5% from volume and 1.5% from price. India grew 1.8% with 2.4% underlying volume growth. Tonnage volume grew mid-single digit, which was partially offset by adverse mix due to the strong growth in Home Care. The business continued to increase market share during a period of modest market growth. Underlying price returned to positive in the fourth quarter on the back of rising input cost inflation. Latin America grew 6.0% with positive volume growth across Brazil, Mexico and Argentina. Growth slowed in the second half, reflecting a deterioration of economic conditions in the region. Africa and Turkey delivered double-digit growth with positive volumes and price in each quarter.
     
    China declined mid-single digit with market weakness across all categories apart from Foods. In the context of softer markets, we are accelerating our portfolio premiumisation and transforming our go-to-market approach to effectively serve fast-growing e-commerce channels and smaller format stores in lower tier cities. 
     
    In South East Asia, volume-led growth in the Philippines and Thailand was offset by an 8.7% decline in Indonesia. In the second half, we took decisive actions by correcting misaligned pricing across channels and resetting stock levels in retail, while also addressing our long-standing issues of portfolio, brand, and competitiveness. This will take several quarters. As we have said previously, we expect to see the benefits of the changes in Indonesia and China from the second half of 2025.
     
     
    (a) Turnover-weighted market share movement: global aggregate of Unilever value market share changes, weighted by the turnover of the category-country combinations
     
    Profitability
    (unaudited)
    UOP
    UOP growth
    UOM%
    Change in
    UOM
    OP
    OP growth
    OM%
    Change in
    OM
    Full Year
    €11.2bn
    12.6%
    18.4%
    170bps
    €9.4bn
    (3.7)%
    15.5%
    (90)bps
     
    Underlying operating profit was €11.2 billion, up 12.6% versus the prior year. Underlying operating margin increased 170bps to 18.4%. This step-up in profitability contributed to a 190bps increase in underlying ROIC to 18.1%.
     
    We expanded gross margin by 280bps to 45.0%, the highest it has been in a decade. Continuing to improve gross margin remains a key focus for the business. Our gross margin improvement in 2024 reflects positive contributions from volume leverage, mix and net productivity gains in material, production and logistics costs. It was also helped by input cost deflation in the first half, which turned into slight inflation in the second half.
     
    Improved gross margin fuelled further increases in brand and marketing investment behind a strong and focused innovation programme. Investment was up 120bps to 15.5% of turnover, an increase of €0.9 billion. Overheads reduced by 10bps, as a result of tighter cost control and savings in the second half from the productivity programme.
     
    Operating profit of €9.4 billion decreased 3.7% versus the prior year. This reduction was driven by higher non-underlying charges, most notably a loss on disposals and higher restructuring costs as a result of accelerating the productivity programme.
     
    Productivity programme
     
    In March 2024, we announced the launch of a major productivity programme to simplify the business and further evolve our category-focused model. The programme is targeted to deliver €800 million of savings, with a reduction of 7,500 mainly office-based roles, creating a leaner and more accountable organisation. Including this programme, we expect average restructuring costs to be around 1.2% of Group turnover over the three-year period from 2024 to 2026.
     
    Following thorough consultation processes, the programme is ahead of plan with a reduction of 4,300 FTEs by the end of 2024 and in-year savings close to €200 million. Restructuring costs, including the accelerated productivity programme, increased to €850 million, equivalent to 1.4% of Group turnover in 2024. We anticipate a similar restructuring cost of approximately 1.4% of Group turnover in 2025 with a lower spend in 2026.
     
    The new organisation structure went live on 1 January 2025. This enables the Business Groups to focus on the top 24 markets, which represent approximately 85% of Group turnover, and the 30 Power Brands. The remaining smaller markets are now run on a 'One Unilever' basis to benefit from scale and simplicity, further enhancing our portfolio prioritisation and focus.
     
    Ice Cream separation
     
    The separation of Ice Cream is on track to complete by the end of 2025. We are making progress on the key workstreams, including the legal entities set up, implementing the standalone operating model and preparing the carve-out financials.
     
    Jean-Francois van Boxmeer has been appointed as Chair Designate for the separated Ice Cream business. Jean-Francois brings a wealth of experience both as a non-executive and as an executive operating within the consumer goods industry. Jean-Francois is currently Chair of Vodafone Group Plc and non-executive director of Heineken Holding N.V. having been Chief Executive of Heineken for 15 years.
     
    Ice Cream will be separated by way of demerger, through listing of the business in Amsterdam, London and New York, the same three exchanges on which Unilever PLC shares are currently traded. The Ice Cream business will be incorporated in the Netherlands and will continue to be headquartered in Amsterdam. This decision follows a full review by the Board of separation options, focused on maximising returns for shareholders, setting the Ice Cream business up for success and execution certainty by the end of 2025.
     
    Capital allocation
     
    We continued to reshape our portfolio, allocating capital to premium segments through bolt-on acquisitions and divesting lower-growth businesses. In February 2024, we acquired K18, a premium biotech hair care brand. We completed several disposals during the year. These included Elida Beauty, our stake in Qinyuan Group (known as "Truliva"), a water purification business in China, and Pureit, a water purification business in Asia and Mexico. In October, we completed the sale of our Russian subsidiary to Arnest Group. The sale included all of Unilever's business in Russia and its four factories, as well as our business in Belarus. In addition, we announced several disposals that we expect to complete during 2025, including the sale of the Foods brands Unox, Conimex and Zwan, as well as the disposal of our laundry business in Central America.
     
    In January 2025, Hindustan Unilever Limited announced it has signed an agreement to acquire the premium actives-led beauty brand Minimalist, as we continue to evolve our Beauty & Wellbeing portfolio towards higher growth and demand spaces in India. 
     
    In 2024, we returned €5.8 billion to shareholders through dividends and share buybacks. The quarterly interim dividend for the fourth quarter is raised to €0.4528, up 6.1% vs Q4 2023.
     
    Following the completion of a €1.5 billion share buyback programme in November, we announce a new share buyback of up to €1.5 billion starting today and to be completed in the first half, well ahead of the separation of Ice Cream.   
     
     
    Conference Call
     
    Following the release of this trading statement on 13 February 2025 at 7:00 AM (UK time), there will be a webcast at 8:00 AM available on the website www.unilever.com/investor-relations/results-and-presentations/latest-results.
     
    A replay of the webcast and the slides of the presentation will be made available after the live meeting.
     
    Upcoming Events
     
    Date
     
    Events
    24 April 2025
    Q1 2025 trading statement
     
    Full Year Review: Business Groups
     
     
    Full Year 2024
    Fourth Quarter 2024
    (unaudited)
                            Turnover
                                 USG
                                    UVG
                                    UPG
                                 UOM
    Change in
    UOM
                                 Turnover
                                   USG
                                 UVG
                       UPG
    Unilever
     
    €60.8bn
     
    4.2%
     
    2.9%
     
    1.3%
     
    18.4%
     
    170bps
     
    €14.2bn
     
    4.0%
     
    2.7%
     
    1.3%
     
    Beauty & Wellbeing
     
    €13.2bn
    6.5%
    5.1%
    1.3%
    19.4%
    70bps
    €3.3bn
    5.2%
    3.9%
    1.2%
    Personal Care
     
    €13.6bn
     
    5.2%
     
    3.1%
     
    2.1%
     
    22.1%
     
    190bps
     
    €3.3bn
     
    5.3%
     
    3.6%
     
    1.6%
     
    Home Care
     
    €12.3bn
     
    2.9%
     
    4.0%
     
    (1.1)%
     
    14.5%
     
    220bps
     
    €3.0bn
     
    3.0%
     
    3.3%
     
    (0.3)%
     
    Foods
     
    €13.4bn
     
    2.6%
     
    0.2%
     
    2.4%
     
    21.3%
     
    270bps
     
    €3.4bn
     
    2.6%
     
    0.5%
     
    2.1%
     
    Ice Cream
    €8.3bn
    3.7%
    1.6%
    2.1%
    11.8%
    100bps
    €1.2bn
    4.3%
    2.2%
    2.0%
     
    Beauty & Wellbeing (22% of Group turnover)
    In Beauty & Wellbeing, we focus on three key priorities: premiumising our core Hair and Skin Care portfolio by emphasising brand superiority; fuelling the growth of our Prestige Beauty and Wellbeing portfolios with selective international expansion; and, continuing to strengthen our competitiveness through innovation and a social-first approach to consumer engagement.
     
    (unaudited)
                          Turnover           
        USG
    UVG
    UPG
    A&D
    Currency
    Turnover
    change
    UOM%
    Change in
    UOM
    Full Year
     
    €13.2bn
     
    6.5%
     
    5.1%
     
    1.3%
     
    (0.3)%
     
    (0.6)%
     
    5.5%
     
    19.4%
     
    70bps
     
    Fourth Quarter
    €3.3bn
    5.2%
    3.9%
    1.2%
    (0.7)%
    (0.4)%
    4.1%
     
     
     
    Beauty & Wellbeing delivered a strong full year performance, with underlying sales up 6.5%, driven by volume at 5.1% and price at 1.3%. Volume growth was broad-based with strong performances from its Power Brands including Sunsilk, Dove, Vaseline, Ponds, Liquid I.V. and Nutrafol. In Q4, Beauty & Wellbeing grew 5.2% with 3.9% volume.
     
    The full year performance reflects the ongoing premiumisation of our core Hair Care and Skin Care portfolio and the continued strength of our Prestige Beauty and Wellbeing portfolio, which combined accounted for c. 30% of Beauty & Wellbeing's turnover. 
     
    Hair Care grew mid-single digit with balanced volume and price growth. Our largest hair care brand, Sunsilk, grew high-single digit reflecting the continued success of its 2023 relaunch and introduction of new formats. Dove delivered high-single digit volume-led growth following the launch of Scalp + Hair Therapy, designed for improved scalp health and hair density. TRESemmé grew mid-single digit following the launch of the Lamellar Shine collection. Clear grew low-single digit amidst low market growth in its primary market China.
     
    Core Skin Care grew mid-single digit led by low-single digit volume and positive price. Vaseline grew double-digit with the expansion of its premium Gluta-Hya range to new markets and new formats. Gluta-Hya is now in over 22 markets and has introduced a new serum based suncare range. Dove skin care delivered double-digit growth, with the launch of its body serums and 3-in-1 face care treatments in Brazil, Mexico, and most recently in the US. Pond's grew double-digit led by volume following its successful relaunch in 2023.
     
    Wellbeing grew strong double-digit led by Liquid I.V., Nutrafol, and Olly. Liquid I.V. saw continued success of its sugar-free variant and ongoing international expansion, entering seven new markets during the year. Nutrafol extended into skin care with a daily supplement designed to address acne, while Olly saw strong growth in China led by its female health supplements. Prestige Beauty grew mid-single digit reflecting a slowdown in the US beauty market. Hourglass and Tatcha grew double-digit while other brands including Paula's Choice delivered low growth. During the year, we completed the acquisition of K18, a premium biotech hair care brand, which grew double-digit and will be included in underlying sales growth from February 2025.
     
    Underlying operating margin improved 70bps with strong gross margin improvement partially reinvested in increased brand and marketing investment.
     
    Personal Care (22% of Group turnover)
    In Personal Care, we focus on winning with science-led brands that deliver unmissable superiority to our consumers across Deodorants, Skin Cleansing, and Oral Care. Our priorities include developing superior technology and multi-year innovation platforms, leveraging partnerships with our customers, and expanding into premium areas and digital channels.
     
    (unaudited)
    Turnover
    USG
    UVG
    UPG
    A&D
    Currency
    Turnover
    change
    UOM%
    Change in
    UOM
    Full Year
     
    €13.6bn
     
    5.2%
     
    3.1%
     
    2.1%
     
    (5.3)%
     
    (1.1)%
     
    (1.5)%
     
    22.1%
     
    190bps
     
    Fourth Quarter
    €3.3bn
    5.3%
    3.6%
    1.6%
    (8.1)%
    (1.7)%
    (5.0)%
     
     
     
    Personal Care grew underlying sales 5.2% for the year with volume growth of 3.1%. This growth was led by continued strength in Deodorants. In the fourth quarter, Personal Care grew 5.3% with Deodorants, Skin Cleansing, and Oral Care all delivering volume growth.
     
    Personal Care's full year performance was led by its Power Brands and science-backed innovations. These innovations were supported by a step-up in marketing investment, including our five-year sponsorship deal with the Fédération Internationale de Football Association (FIFA), and our sponsorship of several major football tournaments worldwide, including UEFA EURO 2024 and the CONMEBOL Copa America USA 2024.
     
    Dove, which represents c. 40% of Personal Care's turnover, grew high-single digit with the successful launches of a new range of whole-body deodorants and a serum shower collection, using active face care ingredients in body wash formats. 
     
    Deodorants grew double-digit led by mid-single digit volume growth. This included Rexona and Axe which grew high-single digit, driven by ongoing success from multi-year innovations, including our body heat-activated technology and our Fine Fragrance collection.
     
    Skin Cleansing grew low-single digit with positive volume and price. Good growth in Dove was partially offset by declines in Lifebuoy and Lux, driven by challenges in Indonesia, China, and India.
     
    Oral Care grew mid-single digit led by price. Our Power Brands, Close up and Pepsodent, grew mid-single digit with positive price and volume. Pepsodent launched its therapeutics range specifically formulated for sensitive teeth.
     
    Underlying operating margin increased by 190bps, driven by a very strong gross margin improvement fuelling increased brand and marketing investment.
     
    Home Care (20% of Group turnover)
    In Home Care, we focus on delivering for consumers who want superior products that are sustainable and great value. We drive growth through unmissable superiority in our biggest brands, in our key markets and across channels. We have a resilient business that spans price points and grows the market by premiumising and trading consumers up to additional benefits.
     
    (unaudited)
    Turnover
    USG
    UVG
    UPG
    A&D
    Currency
    Turnover
    change
    UOM%
    Change in
    UOM
    Full Year
     
    €12.3bn
     
    2.9%
     
    4.0%
     
    (1.1)%
     
    (0.9)%
     
    (0.5)%
     
    1.4%
     
    14.5%
     
    220bps
     
    Fourth Quarter
    €3.0bn
    3.0%
    3.3%
    (0.3)%
    (2.4)%
    (1.0)%
    (0.5)%


     
    Home Care grew underlying sales 2.9%, with 4.0% from volume and (1.1)% from price. Home Care faced the highest commodity cost deflation across Unilever which impacted laundry powders in several emerging markets. 
     
    In Home Care, we stepped up multi-year, scalable innovations with several key launches as well as extending successful 2023 launches. These Power Brand focused innovations drove a return to strong growth in Europe and were supported by increased investments in brand and marketing and R&D to drive unmissable brand superiority. 
     
    Fabric Cleaning was flat with low-single digit volume growth fully offset by negative price. Volume growth was supported by the launch of Persil Wonder Wash, the first liquid detergent designed for short cycle washes. Wonder Wash, powered by our patented Pro-S technology, has been launched in 8 markets and is on track to be in 20 markets by the end of 2025. Europe grew double-digit with strong volumes. Brazil experienced the most significant price declines among our key markets reflecting commodity deflation, notably in our powders portfolio.
     
    Home & Hygiene grew high-single digit with strong volume and positive price. Both Domestos and CIF grew double-digit led by volume, with contributions from the Power Foam, cream and sprays portfolio.
     
    Fabric Enhancers grew high-single digit driven by strong volumes, slightly offset by negative price. The successful launch of our new Botanicals and Elixir ranges, utilising our patented CrystalFresh technology drove a good Comfort performance.
     
    Underlying operating margin increased by 220bps, driven by strong gross margin improvement which was slightly offset by a step-up in brand and marketing investment.
     
    Foods (22% of Group turnover)
    In Foods (formerly known as Nutrition), our strategy is to deliver consistent, competitive growth by offering unmissably superior products through our biggest brands. We do this by reaching more consumers and focusing on top dishes and high consumption seasons to satisfy consumer's preferences on taste, health and sustainability; while delivering productivity and resilience in our supply chain.
     
    (unaudited)
    Turnover
    USG
    UVG
    UPG
    A&D
    Currency
    Turnover
    change
    UOM%
    Change in
    UOM
    Full Year
     
    €13.4bn
     
    2.6%
     
    0.2%
     
    2.4%
     
    (0.5)%
     
    (1.0)%
     
    1.1%
     
    21.3%
     
    270bps
     
    Fourth Quarter
    €3.4bn
    2.6%
    0.5%
    2.1%
    (0.7)%
    (1.4)%
    0.5%
     
     
     
    Foods grew underlying sales 2.6% for the year, with 2.4% from price and 0.2% from volume. Our two largest brands, Hellmann's and Knorr, which accounted for c. 60% of the Business Group, continued to grow ahead of the Foods average. In the fourth quarter, Foods grew 2.6% while market growth remained muted.
     
    In Foods we are creating a more focused and simplified business concentrated on Cooking Aids, Condiments, Mini Meals, Unilever Food Solutions, and our India local Foods portfolio. These categories are where we will lead and where we can best concentrate our investment behind our global Power Brands, Knorr and Hellmann's.
     
    Cooking Aids grew mid-single digit with positive price and volume. Knorr performed well with mid-single digit growth driven by its leadership in bouillon and seasonings and its expansion of premium ready-to-eat pots ranges. Knorr grew double-digit in Latin America through its focus on local dishes and next generation bouillon & seasoning ranges with enhanced flavours and micronutrients.
     
    Condiments grew low-single digit with balanced volume and price growth. Hellmann's grew low-single digit led by volume growth as it continued to expand its Flavoured Mayo range, now in 30 countries, and grow its premium format variants, including new squeeze bottles. 
     
    Unilever Food Solutions grew high-single digit led by volume with positive price. This growth was supported by the rollout of our operator solutions including the latest edition of our Future Menu's Trend Report, now utilised in over 50 countries, and expansion of our digital selling programme, which improved product availability and reach. Growth also benefited from the launch of Hellmann's Professional Mayo in Europe and Brazil, tailored for professional kitchens. China grew high-single digit following a strong Chinese New Year in the first half of the year.
     
    India Foods was flat, as tea and functional drinks maintained market leadership in subdued markets.
     
    Underlying operating margin increased significantly, up 270bps, driven by strong gross margin improvement which funded an increase in brand and marketing investment.
     
     
    Ice Cream (14% of Group turnover)
    In Ice Cream, we are focused on continuing to strengthen the business in preparation for Ice Cream's separation by the end of 2025. We are doing this by developing an exciting product pipeline, designing more efficient go-to-market strategies, optimising our supply chain, and building a dedicated sales team globally. The separation will create a world-leading business, operating in a highly attractive category with five of the top 10 selling global ice cream brands.
    (unaudited)
    Turnover
    USG
    UVG
    UPG
    A&D
    Currency
    Turnover
    change
    UOM%
    Change in
    UOM
    Full Year
     
    €8.3bn
     
    3.7%
     
    1.6%
     
    2.1%
     
    0.9%
     
    (0.1)%
     
    4.5%
     
    11.8%
     
    100bps
     
    Fourth Quarter
    €1.2bn
    4.3%
    2.2%
    2.0%
    (2.1)%
    (0.3)%
    1.8%
     
     
     
    Ice Cream grew underlying sales 3.7%, with 1.6% from volume and 2.1% from price, marking a return to positive volume growth. In the fourth quarter, Ice Cream grew by 4.3%, driven by 2.2% volume growth and 2.0% price growth.
     
    The improving performance in 2024 was fuelled by strong innovations and operational improvements. These ongoing improvements included a more efficient go-to-market strategy, improved distribution, and optimised promotional activities. Share performance improved throughout the year and we sharpened our focus on net productivity, which supported gross margin expansion and reinvestment in our brands.
     
    In-home Ice Cream (c. 60% of Ice Cream turnover) grew low-single digit led by volume growth. This was supported by several snacking innovations with smaller portions. Magnum launched premium, bite-sized Bon Bons, designed to meet evolving snacking habits. The range is performing well and is now in 12 markets with further rollout planned for next year. Joining the small indulgence format, Yasso introduced Poppables, a Greek yogurt-based snack, while Ben & Jerry's expanded its Peaces range with new flavours like Salted Caramel Brownie.
     
    Out-of-home Ice Cream (c. 40% of Ice Cream turnover) grew mid-single digit fully led by price. We launched several premium innovations this year including Magnum's Pleasure Express featuring flavour filled cores and Ben & Jerry's new oat base for its non-dairy ice creams. Cornetto celebrated its 60th anniversary with its first global relaunch featuring enhanced formulation and new packaging.
     
    Underlying operating margin increased by 100bps, driven by improved gross margins which supported an increase in brand and marketing investment. This margin improvement was realised despite higher commodity costs in cocoa and dairy. We expect rising inflation in cocoa and dairy costs to put pressure on margins in 2025.
     
    Full Year Review: Geographical Areas
     
     
    Full Year 2024
    Fourth Quarter 2024
    (unaudited)
    Turnover
    USG
    UVG
    UPG
    Turnover
    USG
    UVG
    UPG
    Unilever
    €60.8bn
    4.2%
    2.9%
    1.3%
    €14.2bn
    4.0%
    2.7%
    1.3%
    Asia Pacific Africa
    €26.0bn
    3.1%
    1.8%
    1.3%
    €6.0bn
    3.1%
    1.4%
    1.6%
    The Americas
    €22.5bn
    5.5%
    4.0%
    1.4%
    €5.5bn
    5.4%
    3.9%
    1.5%
    Europe
    €12.3bn
    4.3%
    3.0%
    1.2%
    €2.7bn
    3.5%
    3.4%
    0.1%
     
     
    Full Year 2024
    Fourth Quarter 2024
    (unaudited)
    Turnover
    USG
    UVG
    UPG
    Turnover
    USG
    UVG
    UPG
    Emerging markets
     
    €35.3bn
     
    4.1%
     
    2.5%
     
    1.5%
     
    €8.1bn
    3.0%
     
    1.1%
     
    1.9%
     
    Developed markets
    €25.5bn
    4.4%
    3.3%
    1.1%
    €6.1bn
    5.4%
    5.1%
    0.3%
    North America
     
    €13.4bn
     
    5.3%
     
    4.1%
     
    1.1%
     
    €3.4bn
    7.0%
     
    6.5%
     
    0.5%
     
    Latin America
    €9.1bn
    6.0%
    3.9%
    2.0%
    €2.1bn
    3.0%
    -%
    3.0%
     
    Asia Pacific Africa (43% of Group turnover)
     
    Underlying sales growth was 3.1% with 1.8% from volume and 1.3% from price.
     
    India grew 1.8% driven by underlying volume growth at 2.4%. This was primarily driven by Home Care and Beauty & Wellbeing while Personal Care declined. In the fourth quarter, UPG turned positive reflecting commodity movements, while UVG was flat with tonnage volume up mid-single digit, partially offset by adverse mix due to strong growth in Home Care. 
     
    China declined mid-single digit with market weakness across all categories apart from Foods. In the context of softer markets, we are accelerating our portfolio premiumisation and transforming our go-to-market approach to effectively serve fast-growing e-commerce channels and smaller format stores in lower tier cities.
     
    In South East Asia, volume-led growth in the Philippines and Thailand was offset by an 8.7% decline in Indonesia. In the second half, we took decisive actions by correcting misaligned pricing across channels and resetting stock levels in retail, while also addressing our long-standing issues of portfolio, brand, and competitiveness. This will take several quarters. As we have said previously, we expect to see the benefits of the changes in Indonesia and China from the second half of 2025. 
     
    Africa, which represents 3% of Group turnover, grew double-digit with positive volume and price growth throughout the year. Turkey delivered double-digit volume growth, led by Ice Cream and Personal Care, in a hyperinflationary environment.
     
    The Americas (37% of Group turnover)
     
    Underlying sales growth was 5.5% with 4.0% from volume and 1.4% from price.
     
    North America grew 5.3% with 4.1% volume growth, with all Business Groups delivering positive volumes. This improved volume performance was led by strong growth in Beauty & Wellbeing. Growth in Personal Care improved in the second half, helped by a strong performance of Deodorants in the fourth quarter. Ice Cream showed good improvement and returned to volume-driven growth. Our Foods business delivered balanced price and volume growth, while category growth slowed during the year.
     
    Latin America grew 6.0% with 3.9% from volume. Beauty & Wellbeing and Personal Care grew double-digit, while Foods delivered mid-single digit growth. Home Care declined slightly, adversely affected by deflation in the laundry powders market. Volume growth slowed in Brazil and Mexico in the second half, reflecting a much more volatile economic environment. In Argentina we delivered positive volume growth in each quarter despite hyperinflationary pricing and continued to strengthen our market-leading positions and performed well in a challenging environment.
     
    Europe (20% of Group turnover)
     
    Underlying sales grew 4.3% with volume growth of 3.0% and price of 1.2%. Our return to positive volume growth in Europe was underpinned by a strong innovation programme and increased levels of brand investment. Home Care grew double-digit, while Beauty & Wellbeing and Personal Care grew high-single digits. Innovations and improved execution led to a step-up of the Ice Cream performance in the second half and positive volume for the year. Foods declined slightly as a result of active portfolio rationalisation and slowing market growth. Growth was broad-based in Europe, led by mid-single digit growth in the United Kingdom and Germany as well as double-digit growth in Poland.  
     
     
    Additional commentary on the financial statements - Full Year
     
    Finance costs and tax
     
    Net finance costs increased by €118 million to €604 million in 2024. This was driven by higher cost of debt on bonds and commercial paper and lower interest credit from pensions. Net finance costs were 2.5% on average net debt. For 2025, we expect net finance costs to be around 3% on average net debt. This reflects the impact of refinancing maturing debt at higher rates and lower finance income versus 2024.
     
    The underlying effective tax rate for 2024 was 25.8% (2023: 25.6%), as increases, including in non-deductible interest and withholding tax, were largely offset by benefits from tax settlements and other one-off items. Our guidance for 2025 for the underlying effective tax rate remains around 26%. The effective tax rate for 2024 was 29.0%, and included adverse impacts linked to disposals in 2024. This compares with 24.1% in the prior year, which included a benefit related to the disposal of the Dollar Shave Club. 
     
    Joint ventures, associates and other income from non-current investments
     
    Net profit from joint ventures and associates increased €24 million to €255 million, largely driven by the Pepsi-Lipton JVs. Other income from non-current investments was €13 million, versus €(22) million in the prior year.
     
    Earnings per share
     
    Underlying earnings per share increased 14.7% to €2.98, including (0.7)% of adverse currency. Constant underlying earnings per share increased by 15.4%, reflecting a strong operational performance. The reduction in the average number of shares as a result of the share buyback programme contributed 1.0%. Diluted earnings per share of €2.29 decreased by 10.6% versus 2023 due to loss on disposals and the accelerated productivity programme spend.
     
    Free cash flow
     
    We delivered strong cash conversion of 106%. Free cash flow was €6.9 billion versus €7.1 billion in 2023. The prior year comparator included a higher tax refund of €0.4 billion in India and a significant working capital improvement of €0.8 billion.
     
    Underlying return on invested capital
     
    Underlying return on invested capital improved 190bps to 18.1% (2023: 16.2%). This reflected strong underlying operating profit growth driven by turnover growth and underlying operating margin expansion, while average invested capital in 2024 was up €0.5 billion versus the prior year. Reported return on invested capital decreased by 180bps to 14.5% driven by a decrease in operating profit from higher non-underlying charges including the loss on disposals and accelerated productivity programme spend.
     
    Net debt
     
    Closing net debt increased €0.9 billion to €24.5 billion in 2024. Net debt to underlying EBITDA was 1.9x at 31 December 2024, versus the prior year at 2.1x and in line with our guidance of around 2x.
     
    Pensions
     
    Pension assets net of liabilities were in surplus of €3.0 billion at 31 December 2024 versus a surplus of €2.4 billion at the end of 2023. The increase was primarily driven by strong investment returns in equities, while higher long-term government bond yields led to reductions in both fixed income assets and pension liabilities.
     
    Share buyback programme
     
    On 5 November 2024, we completed the second and final €800 million tranche of our share buyback programme of up to €1.5 billion, initiated on 8 February 2024. The total consideration paid for the repurchase of 13,931,208 shares is recorded within other reserves and the shares are held by Unilever as treasury shares. Under the two tranches of the programme, a total of 27,368,909 ordinary Unilever PLC shares were purchased. 
     
    Reflecting the Group's continued strong cash generation, the Board has approved a new share buyback with an aggregate market value equivalent of up to €1.5 billion which will be bought back in the form of Unilever PLC ordinary shares.
     
    The new share buyback will commence on 13 February 2025 and will complete on or before 6 June 2025. The purpose of the share buyback is to reduce the capital of Unilever PLC and it will take place within the limitations of the authority granted to the Board of Unilever PLC by its general meeting, held on 1 May 2024, pursuant to which the maximum number of shares to be bought back by Unilever PLC is 222,831,091.
     
    Finance and liquidity
     
    In 2024, the following notes matured and were repaid:
     
    ●     March: $500 million 3.25% fixed rate notes
    ●     April: €500 million 0.50% fixed rate notes
    ●     May: $1,000 million 2.60% fixed rate notes
    ●     August: $500 million 0.626% fixed rate notes
    ●     September: £250 million 1.375% fixed rate notes
     
    The following notes were issued:
     
    ●     February: €600 million 3.25% fixed rate notes due 15 February 2032 and €600 million 3.50% fixed rate notes due 15 February 2037
    ●     March: €100 million 3.25% fixed rate notes to be consolidated and form a single series with the €600 million 3.25% fixed rate notes issued in February and due 15 February 2032
    ●     June: $170 million 4.75% fixed rate notes due 27 June 2031
    ●     August: $750 million 4.25% fixed rate notes due 12 August 2027 and $1,000 million 4.625% fixed rate notes due 12 August 2034
     
    On 31 December 2024, Unilever had undrawn revolving 364-day bilateral credit facilities in aggregate of $5,200 million and €2,600 million with a 364-day term out.
     
    Non-GAAP measures
     
    Certain discussions and analyses set out in this announcement include measures which are not defined by generally accepted accounting principles (GAAP) such as IFRS. We believe this information, along with comparable GAAP measurements, is useful to investors because it provides a basis for measuring our operating performance, ability to retire debt and invest in new business opportunities. Our management uses these financial measures, along with the most directly comparable GAAP financial measures, in evaluating our operating performance and value creation. Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information presented in compliance with GAAP. Wherever appropriate and practical, we provide reconciliations to relevant GAAP measures.
     
    Unilever uses 'constant rate', and 'underlying' measures primarily for internal performance analysis and targeting purposes. We present certain items, percentages and movements, using constant exchange rates, which exclude the impact of fluctuations in foreign currency exchange rates. We calculate constant currency values by translating both the current and the prior period local currency amounts using the prior year average exchange rates into euro, except for the local currency of entities that operate in hyperinflationary economies. These currencies are translated into euros using the prior year closing exchange rate before the application of IAS 29. The table below shows exchange rate movements in our key markets.
     
     
     
                              Annual average rate in 2024
                                 Annual average rate in 2023
    Brazilian Real (€1 = BRL)
     
    5.761
     
    5.405
     
    Chinese Yuan (€1 = CNY)
     
    7.751
     
    7.635
     
    Indian Rupee (€1 = INR)
     
    90.652
     
    89.232
     
    Indonesia Rupiah (€1 = IDR)
     
    17,177
     
    16,457
     
    Philippine Peso (€1 = PHP)
     
    62.055
     
    60.110
     
    Mexican Peso (€1 = MXN)
     
    19.589
     
    19.169
     
    Turkish Lira (€1 = TRY)
     
    36.671
     
    31.625
     
    UK Pound Sterling (€1 = GBP)
     
    0.848
     
    0.870
     
    US Dollar (€1 = US $)
    1.085
    1.081
     
    Underlying sales growth (USG)
     
    Underlying sales growth (USG) refers to the increase in turnover for the period, excluding any change in turnover resulting from acquisitions, disposals, changes in currency and price growth in excess of 26% in hyperinflationary economies. Inflation of 26% per year compounded over three years is one of the key indicators within IAS 29 to assess whether an economy is deemed to be hyperinflationary. We believe this measure provides valuable additional information on the underlying sales performance of the business and is a key measure used internally. The impact of acquisitions and disposals (A&D) is excluded from USG for a period of 12 calendar months from the applicable closing date. Turnover from acquired brands that are launched in countries where they were not previously sold is included in USG as such turnover is more attributable to our existing sales and distribution network than the acquisition itself.
     
    The reconciliation of changes in the GAAP measure of turnover to USG is as follows:
     
    (unaudited)
                              Beauty & Wellbeing
                                          Personal Care
                                              Home Care
                                                         Foods
                                                  Ice Cream
                                  Total
    Fourth Quarter
     
     
     
     
     
     
     
    Turnover (€ million)
     
     
     
     
     
     
     
    2023
     
    3,181
     
    3,404
     
    2,974
     
    3,416
     
    1,202
     
    14,177
     
    2024
     
    3,310
     
    3,235
     
    2,960
     
    3,434
     
    1,223
     
    14,162
     
    Turnover growth (%)
     
    4.1
     
    (5.0)
     
    (0.5)
     
    0.5
     
    1.8
     
    (0.1)
     
    Effect of acquisitions (%)
     
    0.9
     
    -
     
    -
     
    -
     
    -
     
    0.2
     
    Effect of disposals (%)
     
    (1.6)
     
    (8.1)
     
    (2.4)
     
    (0.7)
     
    (2.1)
     
    (3.2)
     
    Effect of currency-related items (%), of which:
     
    (0.4)
     
    (1.7)
     
    (1.0)
     
    (1.4)
     
    (0.3)
     
    (1.1)
     
    Exchange rates changes (%)
     
    (1.8)
     
    (3.9)
     
    (3.8)
     
    (3.4)
     
    (0.4)
     
    (3.0)
     
    Extreme price growth in hyperinflationary markets* (%)
     
    1.5
    2.2
    2.9
    2.1
    -
    2.0
    Underlying sales growth (%)
    5.2
    5.3
    3.0
    2.6
    4.3
    4.0
    Full Year
     
     
     
     
     
     
     
    Turnover (€ million)
     
     
     
     
     
     
     
    2023
     
    12,466
     
    13,829
     
    12,181
     
    13,204
     
    7,924
     
    59,604
     
    2024
     
    13,157
     
    13,618
     
    12,352
     
    13,352
     
    8,282
     
    60,761
     
    Turnover growth (%)
     
    5.5
     
    (1.5)
     
    1.4
     
    1.1
     
    4.5
     
    1.9
     
    Effect of acquisitions (%)
     
    0.9
     
    -
     
    -
     
    -
     
    1.2
     
    0.4
     
    Effect of disposals (%)
     
    (1.2)
     
    (5.3)
     
    (0.9)
     
    (0.5)
     
    (0.3)
     
    (1.8)
     
    Effect of currency-related items (%), of which:
     
    (0.6)
     
    (1.1)
     
    (0.5)
     
    (1.0)
     
    (0.1)
     
    (0.7)
     
    Exchange rates changes (%)
     
    (2.2)
     
    (3.0)
     
    (3.6)
     
    (2.8)
     
    (1.9)
     
    (2.8)
     
    Extreme price growth in hyperinflationary markets* (%)
     
    1.6
    1.9
    3.2
    1.9
    1.8
    2.1
    Underlying sales growth (%)
    6.5
    5.2
    2.9
    2.6
    3.7
    4.2
     
    (unaudited)
                                      Asia Pacific Africa
                                                The Americas
                                                         Europe
                                                            Total
    Fourth Quarter
     
     
     
     
     
    Turnover (€ million)
     
     
     
     
     
    2023
     
    6,119
     
    5,388
     
    2,670
     
    14,177
     
    2024
     
    5,988
     
    5,453
     
    2,721
     
    14,162
     
    Turnover growth (%)
     
    (2.1)
     
    1.2
     
    1.9
     
    (0.1)
     
    Effect of acquisitions (%)
     
    -
     
    0.6
     
    -
     
    0.2
     
    Effect of disposals (%)
     
    (3.8)
     
    (2.8)
     
    (2.5)
     
    (3.2)
     
    Effect of currency-related items (%), of which:
     
    (1.3)
     
    (1.8)
     
    1.0
     
    (1.1)
     
    Exchange rates changes (%)
     
    (2.5)
     
    (5.4)
     
    1.0
     
    (3.0)
     
    Extreme price growth in hyperinflationary markets* (%)
     
    1.2
     
    3.8
     
    -
     
    2.0
     
    Underlying sales growth (%)
    3.1
    5.4
    3.5
    4.0
    Full Year
     
     
     
     
     
    Turnover (€ million)
     
     
     
     
     
    2023
     
    26,234
     
    21,531
     
    11,839
     
    59,604
     
    2024
     
    25,991
     
    22,491
     
    12,279
     
    60,761
     
    Turnover growth (%)
     
    (0.9)
     
    4.5
     
    3.7
     
    1.9
     
    Effect of acquisitions (%)
     
    -
     
    1.0
     
    -
     
    0.4
     
    Effect of disposals (%)
     
    (1.2)
     
    (2.9)
     
    (1.2)
     
    (1.8)
     
    Effect of currency-related items (%), of which:
     
    (2.7)
     
    0.9
     
    0.7
     
    (0.7)
     
    Exchange rates changes (%)
     
    (4.1)
     
    (3.0)
     
    0.7
     
    (2.8)
     
    Extreme price growth in hyperinflationary markets* (%)
     
    1.5
     
    4.0
     
    -
     
    2.1
     
    Underlying sales growth (%)
    3.1
    5.5
    4.3
    4.2
    *Underlying price growth in excess of 26% per year in hyperinflationary economies has been excluded when calculating the underlying sales growth in the tables above, and an equal and opposite amount is shown as extreme price growth in hyperinflationary markets.
     
    Turnover growth is made up of distinct individual growth components namely underlying sales, currency impact, acquisitions and disposals. Turnover growth is arrived at by multiplying these individual components on a compounded basis as there is a currency impact on each of the other components. Accordingly, turnover growth is more than just the sum of the individual components.
     
    Underlying price growth (UPG)
     
    Underlying price growth (UPG) is part of USG and means, for the applicable period, the increase in turnover attributable to changes in prices during the period. UPG therefore excludes the impact to USG due to (i) the volume of products sold; and (ii) the composition of products sold during the period. In determining changes in price, we exclude the impact of price growth in excess of 26% per year in hyperinflationary economies as explained in USG above.
     
    Underlying volume growth (UVG)
     
    Underlying volume growth (UVG) is part of USG and means, for the applicable period, the increase in turnover in such period calculated as the sum of (i) the increase in turnover attributable to the volume of products sold; and (ii) the increase in turnover attributable to the composition of products sold during such period. UVG therefore excludes any impact on USG due to changes in prices.
     
    Non-underlying items
     
    Some of our non-GAAP measures are adjusted to exclude items defined as non-underlying. Management considers non-underlying items to be significant, unusual or non-recurring in nature and so believe that separately identifying them helps users to better understand the financial performance of the Group from period to period.
     
    ●      Non-underlying items within operating profit are: gains or losses on business disposals, acquisition and disposal related costs, restructuring costs, impairments and other approved one-off items within operating profit classified here due to their nature and frequency.
    ●      Non-underlying items not in operating profit but within net profit are: net monetary gain/(loss) arising from hyperinflationary economies and significant and unusual items in net finance cost, share of profit/(loss) of joint ventures and associates and taxation.
    ●      Non-underlying items after tax is calculated as non-underlying items within operating profit after tax plus non-underlying items not in operating profit but within net profit after tax.
     
    Consequently, within underlying operating profit we exclude the following items:
     
    ●      Restructuring costs are costs that are directly attributable to a restructuring project. Management define a restructuring project as a strategic, major initiative that delivers cost savings and materially change either the scope of the business or the manner in which the business is conducted.
    ●      Acquisitions and disposal related costs are costs that are directly attributable to a business acquisition or disposal project.
    ●      Impairment of assets including goodwill, intangible assets and property, plant and equipment.
    ●      Gains or losses from the disposal of group companies which arise from business disposal projects.
    ●      Other approved one-off items are those additional matters considered by management to be significant and outside the course of normal operations.
     
    The breakdown of non-underlying items is shown below:
     
    € million
     
                                             Full Year
    (unaudited)
                                                                    2024
                                                                  2023
    Non-underlying items within operating profit before tax
     
    (1,779)
     
    (173)
     
    Acquisition and disposal-related costs(a)
     
    (387)
     
    (242)
     
    (Loss)/gain disposal of group companies(b)
     
    (406)
     
    489
     
    Restructuring costs(c)
     
    (850)
     
    (499)
     
    Impairments(d)
     
    (133)
     
    (1)
     
    Other
     
    (3)
     
    80
     
    Tax on non-underlying items within operating profit
    129
    207
    Non-underlying items within operating profit after tax
     
    (1,650)
     
    34
     
    Non-underlying items not in operating profit but within net profit before tax
     
    (155)
     
    (153)
     
    Interest related to the UK tax audit of intangible income and centralised services
     
    40
     
    (11)
     
    Net monetary loss arising from hyperinflationary economies
     
    (195)
     
    (142)
     
    Tax impact of non-underlying items not in operating profit but within net profit, including non-underlying tax items
     
    90
     
    12
     
    Non-underlying items not in operating profit but within net profit after tax
    (65)
    (141)
    Non-underlying items after tax
    (1,715)
    (107)
    Attributable to:


    Non-controlling interests
    21
    (6)
    Shareholders' equity
    (1,736)
    (101)
     
    (a)  2024 includes a charge of €239 million (2023: €104 million) relating to the revaluation of the minority interest liability of Nutrafol, €54 million related to the Ice Cream separation, and €39 million relating to the acquisition of Yasso.
     
    (b)  2024 net loss arises from the disposals of Russia, Elida Beauty, PureIt, and Qinyuan. This net loss includes a foreign currency translation reserve write-off of €545 million. 2023 includes a gain of €497 million related to the disposal of Suave.
     
    (c)   In 2024, we announced the launch of a company-wide Productivity programme that would impact around 7,500 jobs and support margin improvement through specific interventions over its duration. The majority of the costs incurred that relate to the Productivity programme were for redundancy and are recognised as restructuring in line with our policy. The remaining cost comprise technology and supply chain projects.
     
    (d)  2024 includes an impairment charge of €127 million relating to Blueair, an air purification business.
     
    Underlying operating profit (UOP) and underlying operating margin (UOM)
     
    Underlying operating profit and underlying operating margin mean operating profit and operating margin before the impact of non-underlying items within operating profit. Underlying operating profit represents our measure of segment profit or loss as it is the primary measure used for making decisions about allocating resources and assessing performance of the segments. The reconciliation of operating profit to underlying operating profit is as follows:
     
    € million
     
                                                       Full Year
    (unaudited)
                                                                          2024
                                                                    2023
    Operating profit
     
    9,400
     
    9,758
     
    Non-underlying items within operating profit
     
    1,779
     
    173
     
    Underlying operating profit
    11,179
    9,931
    Turnover
     
    60,761
     
    59,604
     
    Operating margin (%)
     
    15.5
     
    16.4
     
    Underlying operating margin (%)
    18.4
    16.7
     
    Underlying effective tax rate
     
    The underlying effective tax rate is calculated by dividing taxation excluding the tax impact of non-underlying items by profit before tax excluding the impact of non-underlying items and share of net (profit)/loss of joint ventures and associates. This measure reflects the underlying tax rate in relation to profit before tax excluding non-underlying items before tax and share of net profit/(loss) of joint ventures and associates. Tax impact on non-underlying items within operating profit is the sum of the tax on each non-underlying item, based on the applicable country tax rates and tax treatment. This is shown in the following table:
     
    € million
     
                                                                 Full Year
    (unaudited)
                                                                         2024
                                                                    2023
    Taxation
     
    2,500
     
    2,199
     
    Tax impact of:
     
     
     
    Non-underlying items within operating profit
     
    129
     
    207
     
    Non-underlying items not in operating profit but within net profit
     
    90
     
    12
     
    Taxation before tax impact of non-underlying items
    2,719
    2,418
    Profit before taxation
     
    8,869
     
    9,339
     
    Share of net profit of joint ventures and associates
     
    (255)
     
    (231)
     
    Profit before tax excluding share of net profit of joint ventures and associates
     
    8,614
    9,108
    Non-underlying items within operating profit before tax
     
    1,779
     
    173
     
    Non-underlying items not in operating profit but within net profit before tax
    155
    153
    Profit before tax excluding non-underlying items before tax and share of net profit of joint ventures and associates
    10,548
    9,434
    Effective tax rate (%)
    29.0
    24.1
    Underlying effective tax rate (%)
    25.8
    25.6
     
    Underlying earnings per share
     
    Underlying earnings per share (underlying EPS) is calculated as underlying profit attributable to shareholders' equity divided by the diluted average number of ordinary shares. In calculating underlying profit attributable to shareholders' equity, net profit attributable to shareholders' equity is adjusted to eliminate the post-tax impact of non-underlying items. This measure reflects the underlying earnings for each share unit of the Group. Refer to note 6 for reconciliation of net profit attributable to shareholders' equity to underlying profit attributable to shareholders' equity.
     
    The reconciliation of net profit attributable to shareholders' equity to underlying profit attributable to shareholders' equity is as follows:
     
    € million
     
                                                         Full Year
    (unaudited)
                                                                  2024
                                                                    2023
    Net profit
     
    6,369
     
    7,140
     
    Non-controlling interest
    (625)
    (653)
    Net profit attributable to shareholders' equity - used for basic and diluted earnings per share
     
    5,744
     
    6,487
     
    Post-tax impact of non-underlying items attributable to shareholders' equity
    1,736
    101
    Underlying profit attributable to shareholders' equity - used for basic and diluted earnings per share
    7,480
    6,588
    Adjusted average number of shares (millions of share units)
    2,507.1
    2,532.4
    Diluted EPS (€)
    2.29
    2.56
    Underlying EPS - diluted (€)
    2.98
    2.60
     
    Constant underlying EPS
     
    Constant underlying earnings per share (constant underlying EPS) is calculated as underlying profit attributable to shareholders' equity at constant exchange rates and excluding the impact of both translational hedges and price growth in excess of 26% per year in hyperinflationary economies divided by the diluted average number of ordinary shares. This measure reflects the underlying earnings for each share unit of the Group in constant exchange rates.
     
    The reconciliation of underlying profit attributable to shareholders' equity to constant underlying earnings attributable to shareholders' equity and the calculation of constant underlying EPS is as follows:
     
    € million
     
                                                              Full Year
    (unaudited)
                                                                          2024
                                                                    2023
    Underlying profit attributable to shareholders' equity
     
    7,480
     
    6,588
     
    Impact of translation from current to constant exchange rates and translational hedges
     
    272
     
    (45)
     
    Impact of price growth in excess of 26% per year in hyperinflationary economies
     
    (274)
     
    -
     
    Constant underlying earnings attributable to shareholders' equity
    7,478
    6,543
    Diluted average number of share units (millions of units)
    2,507.1
    2,532.4
    Constant underlying EPS (€)
    2.98
    2.58
     
    Net debt
     
    Net debt is a measure that provides valuable additional information on the summary presentation of the Group's net financial liabilities and is a measure in common use elsewhere. Net debt is defined as the excess of total financial liabilities, excluding trade payables and other current liabilities, over cash, cash equivalents and other current financial assets, excluding trade and other current receivables, and non-current financial asset derivatives that relate to financial liabilities.
     
    The reconciliation of total financial liabilities to net debt is as follows:
     
    € million
     
                                                                Full Year
    (unaudited)
                                                                       2024
                                                                 2023
    Total financial liabilities
     
    (32,053)
     
    (29,622)
     
    Current financial liabilities
     
    (6,987)
     
    (5,087)
     
    Non-current financial liabilities
     
    (25,066)
     
    (24,535)
     
    Cash and cash equivalents as per balance sheet
     
    6,136
     
    4,159
     
    Cash and cash equivalents as per cash flow statement
     
    5,950
     
    4,045
     
    Add: bank overdrafts deducted therein
     
    180
     
    116
     
    Less: cash and cash equivalents held for sale
     
    6
     
    (2)
     
    Other current financial assets
     
    1,330
     
    1,731
     
    Non-current financial asset derivatives that relate to financial liabilities
     
    68
     
    75
     
    Net debt
    (24,519)
    (23,657)
     
    Underlying earnings before interest, taxation, depreciation and amortisation (UEBITDA)
     
    Underlying earnings before interest, taxation, depreciation and amortisation means operating profit before the impact of depreciation, amortisation and non-underlying items within operating profit. We only use UEBITDA to assess our leverage level, which is expressed as net debt to UEBITDA. The reconciliation of operating profit to UEBITDA is as follows:
     
    € million
     
                                                                       Full Year
    (unaudited)
                                                                         2024
                                                                     2023
    Net profit
     
    6,369
     
    7,140
     
    Net finance costs
     
    604
     
    486
     
    Net monetary loss arising from hyperinflationary economies
     
    195
     
    142
     
    Share of net profit of joint ventures and associates
     
    (255)
     
    (231)
     
    Other (income)/loss from non-current investments and associates
     
    (13)
     
    22
     
    Taxation
    2,500
    2,199
    Operating profit
     
    9,400
     
    9,758
     
    Depreciation and amortisation
    1,624
    1,578
    Earnings before interest, taxes, depreciation and amortisation (EBITDA)
     
    11,024
     
    11,336
     
    Non-underlying items within operating profit
    1,779
    173
    Underlying earnings before interest, taxes, depreciation and amortisation (UEBITDA)
    12,803
    11,509
     
    Free cash flow (FCF)
     
    Within the Unilever Group, free cash flow (FCF) is defined as cash flow from operating activities, less income taxes paid, net capital expenditure and net interest payments. It does not represent residual cash flows entirely available for discretionary purposes; for example, the repayment of principal amounts borrowed is not deducted from FCF. FCF reflects an additional way of viewing our liquidity that we believe is useful to investors because it represents cash flows that could be used for distribution of dividends, repayment of debt or to fund our strategic initiatives, including acquisitions, if any.
     
    The reconciliation of cash flow from operating activities to FCF is as follows:
     
    € million
     
                                                                          Full Year
    (unaudited)
                                                                      2024
                                                                  2023
    Cash flow from operating activities
     
    12,144
     
    11,561
     
    Income tax paid
     
    (2,625)
     
    (2,135)
     
    Net capital expenditure
     
    (1,934)
     
    (1,703)
     
    Net interest paid
     
    (653)
     
    (632)
     
    Free cash flow
     
    6,932
     
    7,091
     
    Net cash flow (used in)/from investing activities
     
    (625)
     
    (2,294)
     
    Net cash flow used in financing activities
     
    (6,941)
     
    (7,193)
     
     
    Cash conversion
     
    Unilever defines cash conversion as free cash flow excluding tax on disposal as a proportion of net profit, excluding gain/loss on disposal and income from JV, associates and non-current investments. This reflects our ability to convert profit to cash.
     
    € million
     
                                                                              Full Year
    (unaudited)
                                                                        2024
                                                                    2023
    Net profit
     
    6,369
     
    7,140
     
    Loss/(gain) on disposal of group companies
     
    406
     
    (489)
     
    Share of net profit of joint ventures and associates
     
    (255)
     
    (231)
     
    Other (income)/loss from non-current investments and associates
     
    (13)
     
    22
     
    Tax on gain on disposal of group companies
     
    140
     
    (69)
     
    Net profit excluding P&L on disposals, JV, associates, NCI
    6,647
    6,373
    Cash flow from operating activities
     
    12,144
     
    11,561
     
    Free cash flow
     
    6,932
     
    7,091
     
    Cash impact of tax on disposal
     
    111
     
    14
     
    Free cash flow excluding cash impact of tax on disposal
    7,043
    7,105
    Cash conversion from operating activities (%)
    191
    162
    Cash conversion (%)
    106
    111
     
    Underlying return on invested capital (ROIC)
     
    Underlying return on invested capital (ROIC) is a measure of the return generated on capital invested by the Group. The measure provides a guard rail for long-term value creation and encourages compounding reinvestment within the business and discipline around acquisitions with low returns and long payback. Underlying ROIC is calculated as underlying operating profit after tax divided by the annual average of: goodwill, intangible assets, property, plant and equipment, net assets held for sale, inventories, trade and other current receivables, and trade payables and other current liabilities.
     
     € million
     
                                                                           Full Year
    (unaudited)
                                                                         2024
                                                                   2023
    Operating profit
     
    9,400
     
    9,758
     
    Tax on operating profit(a)
    (2,726)
    (2,352)
     
    Operating profit after tax
    6,674
    7,406
     
     
     
    Operating profit
     
    9,400
     
    9,758
     
    Non-underlying items within operating profit
     
    1,779
    173
    Underlying operating profit before tax
     
    11,179
     
    9,931
     
    Tax on underlying operating profit(b)
    (2,882)
    (2,545)
    Underlying operating profit after tax
    8,297
    7,386
    Goodwill
     
    22,311
     
    21,109
     
    Intangible assets
     
    18,590
     
    18,357
     
    Property, plant and equipment
     
    11,669
     
    10,707
     
    Net assets held for sale
     
    119
     
    516
     
    Inventories
     
    5,177
     
    5,119
     
    Trade and other current receivables
     
    6,011
     
    5,775
     
    Trade payables and other current liabilities
     
    (16,690)
     
    (16,857)
     
    Period-end invested capital
    47,187
    44,726
    Average invested capital for the period
    45,957
    45,487
    Return on invested capital (%)
    14.5
    16.3
    Underlying return on invested capital (%)
    18.1
    16.2
    (a)  Tax on operating profit is calculated as operating profit before tax multiplied by the effective tax rate of 29.0% (2023: 24.1%) which is shown on note 4.
    (b)  Tax on underlying operating profit is calculated as underlying operating profit before tax multiplied by the underlying effective tax rate of 25.8% (2023: 25.6%) which is shown on page 16.
     
    Cautionary Statement
     
    This announcement may contain forward-looking statements, including 'forward-looking statements' within the meaning of the United States Private Securities Litigation Reform Act of 1995, concerning the financial condition, results of operations and businesses of the Unilever Group (the 'Group'). All statements other than statements of historical fact are, or may be deemed to be, forward-looking statements. Words and terminology such as 'will', 'aim', 'expects', 'anticipates', 'intends', 'looks', 'believes', 'vision', 'ambition', 'target', 'goal', 'plan', 'potential', 'work towards', 'may', 'milestone', 'objectives', 'outlook', 'probably', 'project', 'risk', 'seek', 'continue', 'projected', 'estimate', 'achieve' or the negative of these terms, and other similar expressions of future performance, results, actions or events, and their negatives, are intended to identify such forward-looking statements. Forward-looking statements also include, but are not limited to, statements and information regarding Unilever's acceleration of its Growth Action Plan, Unilever's portfolio optimisation towards global or scalable brands, the capabilities and potential of such brands, the various aspects of the separation of Ice Cream and its future operational model, strategy, growth potential, performance and returns, Unilever's productivity programme, its impacts and cost savings over the next three years and operation dis-synergies from the separation of Ice Cream, the Group's emissions reduction targets and other climate change related matters (including actions, potential impacts and risks associated therewith). Forward-looking statements can be made in writing but also may be made verbally by directors, officers and employees of the Group (including during management presentations) in connection with this announcement. These forward-looking statements are based upon current beliefs, expectations and assumptions regarding anticipated developments and other factors affecting the Group. They are not historical facts, nor are they guarantees of future performance or outcomes. All forward-looking statements contained in this announcement are expressly qualified in their entirety by the cautionary statements contained or referred to in this section. Readers should not place undue reliance on forward-looking statements.
     
    Because these forward-looking statements involve known and unknown risks and uncertainties, a number of which may be beyond the Group's control, there are important factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements. Among other risks and uncertainties, the material or principal factors which could cause actual results to differ materially from the forward-looking statements expressed in this announcement are: Unilever's ability to successfully separate Ice Cream and realise the anticipated benefits of the separation; Unilever's ability to successfully execute and consummate its productivity programme in line with expected costs to achieve expected savings; Unilever's global brands not meeting consumer preferences; Unilever's ability to innovate and remain competitive; Unilever's investment choices in its portfolio management; the effect of climate change on Unilever's business; Unilever's ability to find sustainable solutions to its plastic packaging; significant changes or deterioration in customer relationships; the recruitment and retention of talented employees; disruptions in Unilever's supply chain and distribution; increases or volatility in the cost of raw materials and commodities; the production of safe and high quality products; secure and reliable IT infrastructure; execution of acquisitions, divestitures and business transformation projects; economic, social and political risks and natural disasters; financial risks; failure to meet high and ethical standards; and managing regulatory, tax and legal matters.
     
    The forward-looking statements speak only as of the date of this announcement. Except as required by any applicable law or regulation, the Group expressly disclaims any intention, obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Group's expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. New risks and uncertainties arise over time, and it is not possible for us to predict those events or how they may affect us. In addition, we cannot assess the impact of each factor on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.
     
    Further details of potential risks and uncertainties affecting the Group are described in the Group's filings with the London Stock Exchange, Euronext Amsterdam and the US Securities and Exchange Commission, including in the Annual Report on Form 20-F 2023 and the Unilever Annual Report and Accounts 2023.
     
     
    Enquiries
     
     
    Media: Media Relations Team
     
    Investors: Investor Relations Team
     
    UK
    +44 78 2527 3767
     
    [email protected]
     
    [email protected]
     
    or
    +44 77 7999 9683
     
    [email protected]
     
     
     
    NL
    +31 62 191 3705
     
    [email protected]
     
     
     
    or
    +31 61 500 8293
     
    [email protected]
     
     
     
     
    After the conference call on 13 February 2025 at 8:00 AM (UK time), the webcast of the presentation will be available at www.unilever.com/investor-relations/results-and-presentations/latest-results.
     
    This Results Presentation has been submitted to the FCA National Storage Mechanism and is available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
     
     
    Consolidated income statement
     
     
    € million
     
                                                                             Full Year
    (unaudited)
                                                  2024
                                                  2023
                                                   Change
    Turnover
     
    60,761
     
    59,604
     
    1.9%
     
    Operating profit
     
    9,400
     
    9,758
     
    (3.7)%
     
    Net finance costs
     
    (604)
     
    (486)
     
     
    Pensions and similar obligations
     
    71
     
    110
     
     
    Finance income
     
    438
     
    442
     
     
    Finance costs
     
    (1,113)
     
    (1,038)
     
     
    Net monetary loss arising from hyperinflationary economies
     
    (195)
    (142)
     
    Share of net profit of joint ventures and associates
     
    255
     
    231
     
     
    Other income/(loss) from non-current investments and associates
     
    13
     
    (22)
     
     
    Profit before taxation
     
    8,869
     
    9,339
     
    (5.0)%
     
    Taxation
     
    (2,500)
     
    (2,199)
     
     
    Net profit
     
    6,369
     
    7,140
     
    (10.8)%
     
     
     
     
     
     
    Attributable to:
     
     
     
    Non-controlling interests
     
    625
     
    653
     
     
    Shareholders' equity
    5,744
    6,487
    (11.5)%
     
     
    Earnings per share
     
     
     
    Basic earnings per share (euros)
     
    2.30
     
    2.58
    (10.6)%
    Diluted earnings per share (euros)
    2.29
    2.56
    (10.6)%
     
     
     
    Consolidated statement of comprehensive income
     
     
    € million
     
                                                                      Full Year
    (unaudited)
                                                                         2024
                                                                     2023
    Net profit
     
    6,369
     
    7,140
     
    Other comprehensive income
     
     
     
    Items that will not be reclassified to profit or loss, net of tax:
     
     
     
    Gains/(losses) on equity instruments measured at fair value through other comprehensive income
     
    60
     
    (28)
     
    Remeasurement of defined benefit pension plans
     
    264
     
    (510)
     
    Items that may be reclassified subsequently to profit or loss, net of tax:
     
     
     
    Gains/(losses) on cash flow hedges
     
    210
     
    (27)
     
    Currency retranslation gains/(losses)
     
    1,389
     
    (1,461)
     
    Total comprehensive income
     
    8,292
     
    5,114
     
     
     
     
    Attributable to:
     
     
     
    Non-controlling interests
     
    712
     
    524
     
    Shareholders' equity
     
    7,580
     
    4,590
     
     
     
    Consolidated statement of changes in equity
     
    (unaudited)
     
     
     
     
     
     
     
     
    € million
    Called
    up share
    capital
    Share
    premium
    account
    Unification
    reserve
    Other
    reserves
    Retained
    profit
    Total
    Non-
    controlling
    interest
    Total
    equity
    1 January 2023
     
    92
    52,844
    (73,364)
    (10,804)
    50,253
    19,021
    2,680
    21,701
    Profit or loss for the period
     
    -
    -
    -
    -
    6,487
    6,487
    653
    7,140
    Other comprehensive income, net of tax:
     
     
     
     
     
     
     
     
     
    Losses on:
     
     
     
     
     
     
     
     
     
    Equity instruments
     
    -
    -
    -
    (27)
    -
    (27)
    (1)
    (28)
    Cash flow hedges
     
    -
    -
    -
    (27)
    -
    (27)
    -
    (27)
    Remeasurements of defined benefit pension plans
     
    -
     
    -
     
    -
     
    -
     
    (508)
     
    (508)
     
    (2)
     
    (510)
     
    Currency retranslation (losses)/gains(a)
    -
    -
    -
    (1,629)
    294
    (1,335)
    (126)
    (1,461)
    Total comprehensive income
     
    -
    -
    -
    (1,683)
    6,273
    4,590
    524
    5,114
    Dividends on ordinary capital
     
    -
    -
    -
    -
    (4,327)
    (4,327)
    -
    (4,327)
    Cancellation of treasury shares(b)
     
    (4)
    -
    -
    5,282
    (5,278)
    -
    -
    -
    Repurchase of shares(c)
     
    -
    -
    -
    (1,507)
    -
    (1,507)
    -
    (1,507)
    Movements in treasury shares(d)
     
    -
    -
    -
    75
    (98)
    (23)
    -
    (23)
    Share-based payment credit(e)
     
    -
    -
    -
    -
    212
    212
    -
    212
    Dividends paid to non-controlling interests
     
    -
    -
    -
    -
    -
    -
    (521)
    (521)
    Hedging (gain)/loss transferred to non-financial assets
     
    -
     
    -
     
    -
     
    117
     
    -
     
    117
     
    -
     
    117
     
    Other movements in equity
    -
    -
    -
    2
    17
    19
    (21)
    (2)
    31 December 2023
     
    88
    52,844
    (73,364)
    (8,518)
    47,052
    18,102
    2,662
    20,764
    Profit or loss for the period
     
    -
    -
    -
    -
    5,744
    5,744
    625
    6,369
    Other comprehensive income, net of tax:
     
     
     
     
     
     
     
     
     
    Gains on:
     
     
     
     
     
     
     
     
     
    Equity instruments
     
    -
    -
    -
    60
    -
    60
    -
    60
    Cash flow hedges
     
    -
    -
    -
    210
    -
    210
    -
    210
    Remeasurements of defined benefit pension plans
     
    -
     
    -
     
    -
     
    -
     
    269
     
    269
     
    (5)
     
    264
     
    Currency retranslation gains(a)
     
    -
    -
    -
    406
    891
    1,297
    92
    1,389
    Total comprehensive income
     
    -
    -
    -
    676
    6,904
    7,580
    712
    8,292
    Dividends on ordinary capital
     
    -
    -
    -
    -
    (4,320)
    (4,320)
    -
    (4,320)
    Cancellation of treasury shares
     
    -
    -
    -
    -
    -
    -
    -
    -
    Repurchase of shares(c)
    -
    -
    -
    (1,508)
    -
    (1,508)
    -
    (1,508)
    Movements in treasury shares(d)
     
    -
    -
    -
    25
    (120)
    (95)
    -
    (95)
    Share-based payment credit(e)
     
    -
    -
    -
    -
    324
    324
    -
    324
    Dividends paid to non-controlling interests
     
    -
    -
    -
    -
    -
    -
    (712)
    (712)
    Hedging (gain)/loss transferred to non-financial assets
     
    -
     
    -
     
    -
     
    (54)
     
    -
     
    (54)
     
    -
     
    (54)
     
    Other movements in equity
     
    -
    -
    -
    80
    (119)
    (39)
    (97)
    (136)
    31 December 2024
    88
    52,844
    (73,364)
    (9,299)
    49,721
    19,990
    2,565
    22,555
     
    (a)  Includes a hyperinflation adjustment of €880 million (2023: €308 million) in relation to Argentina and Turkey.
     
    (b)  During 2023, 112,746,434 PLC ordinary shares held as treasury shares were cancelled. The amount paid to repurchase these shares was initially recognised in other reserves and is transferred to retained profit on cancellation.
     
    (c)   Repurchase of shares reflects the cost of acquiring ordinary shares as part of the share buyback programmes announced on 10 February 2022 and 8 February 2024.
     
    (d)  Includes purchases and sales of treasury shares, other than the share buyback programme and the transfer from treasury shares to retained profit of share-settled schemes arising from prior years and differences between purchase and grant price of share awards.
     
    (e)  The share-based payment credit relates to the non-cash charge recorded against operating profit in respect of the fair value of share options and awards granted to employees.
     
     
    Consolidated balance sheet
     
    (unaudited)
     
     
     
    € million
    As at 31
    December 2024
    As at 31
    December 2023
    Non-current assets
     
     
     
    Goodwill
     
    22,311
     
    21,109
     
    Intangible assets
     
    18,590
     
    18,357
     
    Property, plant and equipment
     
    11,669
     
    10,707
     
    Pension asset for funded schemes in surplus
     
    4,164
     
    3,781
     
    Deferred tax assets
     
    1,280
     
    1,113
     
    Financial assets
     
    1,571
     
    1,386
     
    Other non-current assets
     
    971
     
    911
     
     
    60,556
    57,364
    Current assets
     
     
     
    Inventories
     
    5,177
     
    5,119
     
    Trade and other current receivables
     
    6,011
     
    5,775
     
    Current tax assets
     
    373
     
    427
     
    Cash and cash equivalents
     
    6,136
     
    4,159
     
    Other financial assets
     
    1,330
     
    1,731
     
    Assets held for sale
     
    167
     
    691
     
     
    19,194
    17,902
     
     
     
     
    Total assets
    79,750
    75,266
     
     
     
    Current liabilities
     
     
     
    Financial liabilities
     
    6,987
     
    5,087
     
    Trade payables and other current liabilities
     
    16,690
     
    16,857
     
    Current tax liabilities
     
    678
     
    851
     
    Provisions
     
    831
     
    537
     
    Liabilities held for sale
     
    48
     
    175
     
     
    25,234
    23,507
    Non-current liabilities
     
     
     
    Financial liabilities
     
    25,066
     
    24,535
     
    Non-current tax liabilities
     
    585
     
    384
     
    Pensions and post-retirement healthcare liabilities:
     
     
     
    Funded schemes in deficit
     
    173
     
    351
     
    Unfunded schemes
     
    1,021
     
    1,029
     
    Provisions
     
    571
     
    563
     
    Deferred tax liabilities
     
    4,342
     
    3,995
     
    Other non-current liabilities
     
    203
     
    138
     
     
    31,961
    30,995
     
     
     
     
    Total liabilities
    57,195
    54,502
     
     
     
    Equity
     
     
     
    Shareholders' equity
     
    19,990
     
    18,102
     
    Non-controlling interests
     
    2,565
     
    2,662
     
    Total equity
     
    22,555
    20,764
     
     
     
     
    Total liabilities and equity
    79,750
    75,266
     
     
    Consolidated cash flow statement
     
     
    (unaudited)
     
                                                                    Full Year
    € million
                                                                        2024
                                                                  2023
    Net profit
     
    6,369
     
    7,140
     
    Taxation
     
    2,500
     
    2,199
     
    Share of net profit of joint ventures/associates and other (income)/loss from non-current investments and associates
     
    (268)
     
    (209)
     
    Net monetary loss arising from hyperinflationary economies
     
    195
     
    142
     
    Net finance costs
     
    604
     
    486
     
    Operating profit
    9,400
    9,758
     
     
     
    Depreciation, amortisation and impairment
     
    1,757
     
    1,579
     
    Changes in working capital
     
    (160)
     
    814
     
    Inventories
     
    (198)
     
    340
     
    Trade and other receivables
     
    (206)
     
    768
     
    Trade payables and other liabilities
     
    244
     
    (294)
     
    Pensions and similar obligations less payments
     
    (88)
     
    (281)
     
    Provisions less payments
     
    330
     
    (185)
     
    Elimination of loss/(profits) on disposals
     
    436
     
    (433)
     
    Non-cash charge for share-based compensation
     
    324
     
    212
     
    Other adjustments
     
    145
     
    97
     
    Cash flow from operating activities
     
    12,144
    11,561
    Income tax paid
     
    (2,625)
    (2,135)
    Net cash flow from operating activities
    9,519
    9,426
     
     
     
    Interest received
     
    432
     
    267
     
    Purchase of intangible assets
     
    (233)
     
    (243)
     
    Purchase of property, plant and equipment
     
    (1,738)
     
    (1,502)
     
    Disposal of property, plant and equipment
     
    37
     
    42
     
    Acquisition of businesses and investments in joint ventures and associates
     
    (795)
     
    (704)
     
    Disposal of businesses, joint ventures and associates
     
    985
     
    436
     
    Acquisition of other non-current investments
     
    (166)
     
    (533)
     
    Disposal of other non-current investments
     
    59
     
    62
     
    Dividends from joint ventures, associates and other non-current investments
     
    261
     
    239
     
    Sale/(purchase) of financial assets
     
    533
     
    (358)
     
    Net cash flow used in investing activities
    (625)
    (2,294)
     
     
     
    Dividends paid on ordinary share capital
     
    (4,319)
     
    (4,363)
     
    Interest paid
     
    (1,085)
     
    (899)
     
    Net change in short-term borrowings
     
    643
     
    (570)
     
    Additional financial liabilities
     
    4,741
     
    4,972
     
    Repayment of financial liabilities
     
    (4,306)
     
    (3,905)
     
    Capital element of lease rental payments
     
    (381)
     
    (394)
     
    Repurchase of shares
     
    (1,508)
     
    (1,507)
     
    Other financing activities
     
    (726)
     
    (527)
     
    Net cash flow used in financing activities
    (6,941)
    (7,193)
     
     
     
    Net increase/(decrease) in cash and cash equivalents
    1,953
    (61)
     
     
     
    Cash and cash equivalents at the beginning of the period
     
    4,045
     
    4,225
     
     
     
     
    Effect of foreign exchange rate changes
     
    (48)
     
    (119)
     
     
     
     
    Cash and cash equivalents at the end of the period
    5,950
    4,045
     
     
    Notes to the condensed consolidated financial statements
    (unaudited)
    1.    Accounting information and policies
     
    Except as set out below the accounting policies and methods of computation are consistent with the year ended 31 December 2023. In conformity with the requirements of the Companies Act 2006, the condensed consolidated preliminary financial statements have been prepared based on the International Financial Reporting Standards (IFRS) as issued by the International Accounting Standard Board (IASB) and UK-adopted international accounting standards.
     
    The condensed consolidated financial statements are shown at current exchange rates, and percentage year-on-year changes are shown to facilitate comparison. The consolidated income statement on page 21, the consolidated statement of comprehensive income on page 21, the consolidated statement of changes in equity on page 22 and the consolidated cash flow statement on page 24 are translated at exchange rates current in each period. The balance sheet on page 23 is translated at period-end rates of exchange.
     
    The condensed consolidated financial statements attached do not constitute the full financial statements within the meaning of Section 434 of the UK Companies Act 2006, which will be finalised and delivered to the Registrar of Companies in due course. Full accounts for Unilever for the year ended 31 December 2023 have been delivered to the Registrar of Companies; the auditors' reports on these accounts were unqualified, did not include a reference to any matters by way of emphasis and did not contain a statement under Section 498 (2) or Section 498 (3) of the UK Companies Act 2006.
     
    Accounting developments adopted by the Group
     
    On 1 January 2024, the Group adopted the amendments to IAS 7 and IFRS 7 "Supplier Finance Arrangements". The amendments introduce additional disclosure requirements for companies that enter supplier finance arrangements. This will be disclosed in the financial statements for the year ended 31 December 2024.
     
    All other new standards or amendments issued by the IASB and UK Endorsement Board that were effective by 1 January 2024, were either not applicable or not material to the Group.
     
    2.    Segment information - Business Groups
     
    Fourth Quarter
     
                                                Personal
                                                Care
                                             Home Care
                                               Foods
                                               Ice Cream
                                           Total
    Turnover (€ million)
     
     
     
     
     
     
     
    2023
     
    3,181
     
    3,404
     
    2,974
     
    3,416
     
    1,202
     
    14,177
     
    2024
     
    3,310
     
    3,235
     
    2,960
     
    3,434
     
    1,223
     
    14,162
     
    Change (%)
    4.1
    (5.0)
    (0.5)
    0.5
    1.8
    (0.1)
     
    Full Year
                                             Beauty &
                                            Wellbeing
                                             Personal
                                           Care
                                             Home Care
                                                  Foods
                                            Ice Cream
                                      Total
    Turnover (€ million)
     
     
     
     
     
     
     
    2023
     
    12,466
     
    13,829
     
    12,181
     
    13,204
     
    7,924
     
    59,604
     
    2024
     
    13,157
     
    13,618
     
    12,352
     
    13,352
     
    8,282
     
    60,761
     
    Change (%)
    5.5
    (1.5)
    1.4
    1.1
    4.5
    1.9
     
     
     
     
     
     
     
     
    Operating profit (€ million)
     
     
     
     
     
     
     
    2023
     
    2,209
     
    2,957
     
    1,419
     
    2,413
     
    760
     
    9,758
     
    2024
     
    1,970
     
    2,739
     
    1,521
     
    2,599
     
    571
     
    9,400
     
    Underlying operating profit (€ million)
     
     
     
     
     
     
     
    2023
     
    2,331
     
    2,792
     
    1,496
     
    2,460
     
    852
     
    9,931
     
    2024
    2,552
    3,014
    1,785
    2,847
    981
    11,179
     
    Underlying operating profit represents our measure of segment profit or loss as it is the primary measure used for the purpose of making decisions about allocating resources and assessing performance of segments. Underlying operating margin is calculated as underlying operating profit divided by turnover.
     
     
     
    3.    Segment information - Geographical area
     
     
    Fourth Quarter
                                               Asia Pacific
                                                Africa
                                          The Americas
                                                        Europe
                                                             Total
    Turnover (€ million)
     
     
     
     
     
    2023
     
    6,119
     
    5,388
     
    2,670
     
    14,177
     
    2024
     
    5,988
     
    5,453
     
    2,721
     
    14,162
     
    Change (%)
    (2.1)
    1.2
    1.9
    (0.1)
     
     
    Full Year
                                           Asia Pacific
                                         Africa
                                              The Americas
                                                            Europe
                                                             Total
    Turnover (€ million)
     
     
     
     
     
    2023
     
    26,234
     
    21,531
     
    11,839
     
    59,604
     
    2024
     
    25,991
     
    22,491
     
    12,279
     
    60,761
     
    Change (%)
    (0.9)
    4.5
    3.7
    1.9
     
    4.    Taxation
     
    The effective tax rate for 2024 is 29.0% compared with 24.1% in 2023. For 2024 there is an adverse impact arising from disposals whereas in 2023 there was a benefit.
     
     
    5.    Earnings per share
     
    The earnings per share calculations are based on the average number of share units representing the ordinary shares of PLC in issue during the period, less the average number of shares held as treasury shares.
     
    In calculating diluted earnings per share, a number of adjustments are made to the number of shares, principally the exercise of share plans by employees.
     
    Earnings per share for total operations for the twelve months were calculated as follows:
     
     
     
                                                 Full Year
     
                                                                2024
                                                              2023
    EPS - Basic
     
     
     
    Net profit attributable to shareholders' equity (€ million)
     
    5,744
     
    6,487
     
    Average number of shares (millions of share units)
     
    2,492.6
    2,515.9
    EPS - basic (€)
    2.30
    2.58
     
     
     
     
    EPS - Diluted
     
     
     
    Net profit attributable to shareholders' equity (€ million)
     
    5,744
     
    6,487
     
    Adjusted average number of shares (millions of share units)
     
    2,507.1
     
    2,532.4
     
    EPS - diluted (€)
    2.29
    2.56
     
    During the period the following movements in shares have taken place:
     
     
                                                       Millions
    Number of shares at 31 December 2023 (net of treasury shares)
     
    2,499.0
     
    Shares repurchased under the share buyback programme
     
    (27.4)
     
    Net movements in shares under incentive schemes
     
    4.0
     
    Number of shares at 31 December 2024 (net of treasury shares)
     
    2,475.6
     
     
    6.    Acquisitions and disposals
     
    In 2024, the Group completed the business acquisitions and disposals as listed below.
     
    Deal completion date
    Acquired/disposed business
    1 February 2024
    Acquired 91.88% of K18, a U.S. based premium hair care brand. The acquisition complements Unilever's existing Beauty and Wellbeing portfolio, with a range of high-quality, hair care products.
     
    1 June 2024
    Sold Elida Beauty to Yellow Wood Partners LLC. Elida Beauty comprises more than 20 beauty and personal care brands, such as Q-Tips, Caress, Timotei and TIGI.
     
    1 August 2024
    Sold Qinyuan Group (also known as "Truliva") to Yong Chao Venture Capital Co., Ltd. Qinyuan Group offers a range of water purification solutions to households in China.
     
    8 October 2024
    Sold the Russian subsidiary to Arnest Group. The sale includes all of Unilever's business in Russia and its four factories in the country, along with our business in Belarus.
     
    1 November 2024
    Sold Pureit to A.O. Smith. Pureit offers a range of water purification solutions across India, Bangladesh, Sri Lanka, Vietnam and Mexico, among others.
     
    On 22 January 2025, Hindustan Unilever Limited announced it has signed an agreement to acquire Minimalist, a premium actives-led beauty brand in India. The transaction is expected to be completed by Q2 2025.
     
    Acquisitions
     
    The net consideration for acquisitions in 2024 is €616 million (2023: €675 million for acquisitions completed during that year).
     
    Effect on consolidated income statement
     
    If the acquisition deals completed in 2024 had all taken place at the beginning of the year, Group turnover would have been €60,772 million, and Group operating profit would have been €9,402 million.
     
    Effect on consolidated balance sheet
     
    The following table summarises the consideration and net assets acquired in 2024. The fair values currently used for opening balances are provisional. These balances remain provisional due to there being outstanding relevant information in regard to facts and circumstances that existed as of the acquisition date and/or where valuation work is still ongoing.
     
    € million
                                                                  Total 2024
    Intangible assets
     
    382
     
    Other non-current assets
     
    14
     
    Trade and other receivables
     
    15
     
    Other current assets
     
    36
     
    Non-current liabilities(a)
     
    (99)
     
    Current liabilities
     
    (15)
     
    Net assets acquired
     
    333
     
    Non-controlling interest
     
    (27)
     
    Goodwill
     
    310
     
    Total consideration
     
    616
     
    Of which:
     
     
    Cash consideration paid
     
    616
     
    Deferred consideration
    -
     
    (a)  Non-current liabilities include deferred tax of €99 million.
     
    Disposals
     
    Total consideration for 2024 disposals is €1,396 million (2023: €578 million for disposals completed during that year). The following table sets out the effect of the disposals in 2024 and comparative year on the consolidated balance sheet. The results of disposed businesses are included in the consolidated financial statements up until their date of disposal.
     
    € million
                                                                         2024
                                                                2023
    Goodwill and intangible assets(a)
    1,107
    56
    Other non-current assets
    218
    55
    Current assets(b)
    700
    108
    Liabilities(c)
    (683)
    (144)
    Net assets sold
    1,342
    75
    Loss on recycling of currency retranslation on disposal
    545
    14
    Non-controlling interest
    (85)
    -
    Profit/(loss) on sale attributable to Unilever
    (406)
    489
    Consideration
    1,396
    578
    Of which:
     
     
    Cash(d)
    1,299
    477
    Non-cash items and deferred consideration
    97
    101
     
    (a)  2024 includes intangibles of €984 million relating to the disposals of the Elida Beauty, Russia and Truliva businesses.
     
    (b)  2024 includes inventories of €126 million, cash of €324 million and trade receivables of €215 million.
     
    (c)   2024 includes €431 million of trade payables.
     
    (d)  2024 includes €324 million related to cash balances of businesses sold.
     
    7.    Share buyback
     
    On the 8 February 2024, we announced a share buyback programme for an aggregate market value equivalent of up to €1.5 billion. As at 31 December 2024 the Group repurchased 27,368,909 ordinary shares for €1.5 billion, which will be held as Treasury stock until cancellation.
     
    8.    Financial instruments
     
    The Group's Treasury function aims to protect the Group's financial investments, while maximising returns. The fair value of financial assets is the same as the carrying amount for 2024 and 2023. The Group's cash resources and
     
     
    other financial assets are shown below.
     
     
     
                             31 December 2024
                                                     31 December 2023
    € million
     
                             Current
                                Non-current
                                      Total
                                  Current
                             Non-current
                                             Total
    Cash and cash equivalents
     
     
     
     
     
     
     
    Cash at bank and in hand
     
    3,241
     
    -
     
    3,241
     
    2,862
     
    -
     
    2,862
     
    Short-term deposits(a)
     
    2,436
     
    -
     
    2,436
     
    1,181
     
    -
     
    1,181
     
    Other cash equivalents(b)
     
    459
     
    -
     
    459
     
    116
     
    -
     
    116
     
     
    6,136
    -
    6,136
    4,159
    -
    4,159
    Other financial assets
     
     
     
     
     
     
     
    Financial assets at amortised cost(c)
     
    736
    526
    1,262
    961
    454
    1,415
    Financial assets at fair value through other comprehensive income(d)
     
    -
     
    600
     
    600
     
    151
     
    458
     
    609
     
    Financial assets at fair value through profit or loss:
     
     
     
     
     
     
     
      Derivatives
     
    149
    68
    217
    37
    75
    112
      Other(e)
     
    445
    377
    822
    582
    399
    981
     
    1,330
    1,571
    2,901
    1,731
    1,386
    3,117
    Total financial assets(f)
    7,466
    1,571
    9,037
    5,890
    1,386
    7,276
     
    (a)  Short-term deposits typically have a maturity of up to 3 months.
     
    (b)  Other cash equivalents include investments in overnight funds and marketable securities.
     
    (c)   Current financial assets at amortised cost include short term deposits with banks with maturities longer than three months excluding deposits which are part of a recognised cash management process, fixed income securities and loans to joint venture entities. Non-current financial assets at amortised cost include judicial deposits of €196 million (2023: €227 million).
     
    (d)  Included within non-current financial assets at fair value through other comprehensive income are equity investments.
     
    (e)  Other financial assets at fair value through profit or loss include money market funds, marketable securities, other capital market instruments
     
    and investments in financial institutions.
     
    (f)   Financial assets exclude trade and other current receivables.
     
     
    The Group is exposed to the risks of changes in fair value of its financial assets and liabilities. The following tables summarise the fair values and carrying amounts of financial instruments and the fair value calculations by category.
     
     
     
                    Fair value
                  Carrying amount
    € million
                      As at 31 December 2024
                     As at 31 December 2023
                As at 31 December 2024
              As at 31 December 2023
    Financial assets
     
     
     
     
     
    Cash and cash equivalents
     
    6,136
    4,159
    6,136
    4,159
    Financial assets at amortised cost
     
    1,262
    1,415
    1,262
    1,415
    Financial assets at fair value through other comprehensive income
     
    600
     
    609
     
    600
     
    609
     
    Financial assets at fair value through profit and loss:
     
     
     
     
     
    Derivatives
     
    217
    112
    217
    112
    Other
    822
    981
    822
    981
     
    9,037
    7,276
    9,037
    7,276
    Financial liabilities
     
     
     
     
     
    Bank loans and overdrafts
     
    (521)
    (506)
    (521)
    (506)
    Bonds and other loans
     
    (28,037)
    (26,112)
    (28,648)
    (26,692)
    Lease liabilities
     
    (1,486)
    (1,395)
    (1,486)
    (1,395)
    Derivatives
     
    (594)
    (494)
    (594)
    (494)
    Other financial liabilities
     
    (804)
    (535)
    (804)
    (535)

    (31,442)
    (29,042)
    (32,053)
    (29,622)
     
     
    For assets and liabilities which are carried at fair value, the classification of fair value calculations by category is summarised below:
     
     
     
                                                   As at 31 December 2024
                            As at 31 December 2023
    € million
                                        Level 1
                                         Level 2
                                     Level 3
                                   Level 1
                                        Level 2
                                 Level 3
    Assets at fair value
     
     
     
     
     
     
     
    Financial assets at fair value through other comprehensive income
     
    10
     
    4
     
    586
     
    163
     
    4
     
    442
     
    Financial assets at fair value through profit or loss:
     
     
     
     
     
     
     
    Derivatives(a)
     
    -
    420
    -
    -
    149
    -
    Other
     
    445
    -
    377
    582
    -
    399
    Liabilities at fair value
     
     
     
     
     
     
     
    Derivatives(b)
     
    -
    (650)
    -
    -
    (559)
    -
    Contingent consideration
    -
    -
    (1)
    -
    -
    (157)
     
    (a)  Includes €203 million (2023: €37 million) derivatives, reported within trade receivables, that hedge trading activities.
     
    (b)  Includes €(56) million (2023: €(65) million) derivatives, reported within trade creditors, that hedge trading activities.
     
    There were no significant changes in classification of fair value of financial assets and financial liabilities since 31 December 2023. There were also no significant movements between the fair value hierarchy classifications since 31 December 2023.
     
    The fair value of trade receivables and payables is considered to be equal to the carrying amount of these items due to their short-term nature. The fair value of financial assets and financial liabilities (excluding listed bonds) is considered to be same as the carrying amount for 2024 and 2023.
     
    Calculation of fair values
     
    The fair values of the financial assets and liabilities are defined as the price that would be received to sell an asset
     
    or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Methods and assumptions used to estimate the fair values are consistent with those used in the year ended 31 December 2023.
     
     
    9.    Dividends
     
    The Board has declared a quarterly interim dividend for Q4 2024 of £0.3775 per Unilever PLC ordinary share or €0.4528 per Unilever PLC ordinary share at the applicable exchange rate issued by WM/Reuters on 11 February 2025.
     
    The following amounts will be paid in respect of this quarterly interim dividend on the relevant payment date:
     
    Per Unilever PLC ordinary share (traded on the London Stock Exchange):
     
    £0.3775
     
    Per Unilever PLC ordinary share (traded on Euronext in Amsterdam):
     
    €0.4528
     
    Per Unilever PLC American Depositary Receipt:
    US$0.4674
     
    The euro and US dollar amounts above have been determined using the applicable exchange rates issued by WM/Reuters on 11 February 2025.
     
    US dollar cheques for the quarterly interim dividend will be mailed on 28 March 2025 to holders of record at the close of business on 28 February 2025.
     
    The quarterly dividend calendar for Q4 2024 and the remainder of 2025 will be as follows:
     
     
    Announcement
    Date
    Ex-dividend Date for
    Ordinary Shares
    Ex-dividend Date for
    ADRs
    Record Date
    Last Date for DRIP
    Election
    Payment Date
    Q4 2024 Dividend
     
    13 February 2025
    27 February 2025
    28 February 2025
    28 February 2025
    07 March 2025
    28 March 2025
    Q1 2025 Dividend
     
    24 April 2025
    15 May 2025
    16 May 2025
    16 May 2025
    22 May 2025
    13 June 2025
    Q2 2025 Dividend
     
    31 July 2025
    14 August 2025
    15 August 2025
    15 August 2025
    21 August 2025
    12 September 2025
     
    Q3 2025 Dividend
     
    23 October 2025
     
    06 November 2025
     
    07 November 2025
     
    07 November 2025
     
    14 November 2025
     
    05 December 2025
     
    10.  Events after the balance sheet date
     
    There are no material post balance sheet events other than those mentioned elsewhere in this report.
    Get the next $UL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $UL

    DatePrice TargetRatingAnalyst
    2/9/2026Buy → Hold
    Deutsche Bank
    1/8/2026$71.00Outperform → Neutral
    BNP Paribas Exane
    12/15/2025$60.10Overweight
    Morgan Stanley
    5/29/2025$73.00Outperform
    BNP Paribas Exane
    2/21/2025Hold → Buy
    DZ Bank
    1/6/2025Sector Perform → Underperform
    RBC Capital Mkts
    8/22/2024$47.00 → $72.00Underperform → Buy
    BofA Securities
    7/23/2024$67.00Buy
    TD Cowen
    More analyst ratings

    $UL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Alcoa, Ball and Unilever Partner to Launch the First Use of ELYSIS® Carbon-Free Smelting Technology in Consumer Personal and Home Care Packaging

    Collaboration Marks an Industry Milestone in Advancing Low-Carbon Aluminum for Everyday Products Alcoa Corporation (NYSE:AA, ASX: AAI)) ("Alcoa" or the "Company"), Ball Corporation (NYSE:BALL) and Unilever PLC (NYSE:UL) announced the first use of breakthrough ELYSIS® carbon-free smelting technology in consumer personal and home care packaging. The announcement comes ahead of the 30th United Nations Climate Change Conference (COP30)—a global gathering of government, industry, finance and academic leaders to discuss climate change and the need for collaborative solutions across multiple sectors. This collaboration marks the first time aluminum produced using ELYSIS carbon-free smelting tech

    11/6/25 8:00:00 AM ET
    $AA
    $BALL
    $UL
    Aluminum
    Industrials
    Containers/Packaging
    Package Goods/Cosmetics

    Scoop, There It Is! Doughlivery by Ben & Jerry's Cools Down Torontonians to Celebrate National Ice Cream Day

    Toronto, July 17, 2025 (GLOBE NEWSWIRE) -- This summer, when the Toronto heat hits its peak, Ben & Jerry's is bringing the chill - literally. To celebrate National Ice Cream Day, the iconic ice cream brand will hit the streets with the Doughlivery by Ben & Jerry's truck, an activation offering the chance of free ice cream and a few extra-sweet surprises designed to help Ben & Jerry's fans in Toronto beat the heat in the most delicious way possible. From July 18-20, fans in Toronto can enjoy surprise and delight deliveries on Uber Eats via Doughlivery by Ben & Jerry's. How does it work? Place a restaurant order on UberEats and you could get a free Ben & Jerry's pint through their Doughliv

    7/17/25 12:21:37 PM ET
    $UL
    Package Goods/Cosmetics
    Consumer Discretionary

    Unilever U.S. Issues Allergy Alert on Undeclared Milk in Popsicle Jolly Rancher Single-Serve Frozen Confection Pops

    Only Popsicle Jolly Rancher products marked for individual sale are impacted Unilever in the United States is recalling approximately 137,000 cases of Popsicle Jolly Rancher Frozen Confection Pop products (single serve offerings) because the products may contain milk, which is not listed as an ingredient on the label. Persons who have an allergy or severe sensitivity to milk run the risk of a serious or life-threatening allergic reaction if they consume this product. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240821410508/en/(Photo: Business Wire) The only impacted products are Popsicle Jolly Rancher Frozen Confection Pop

    8/21/24 9:30:00 AM ET
    $UL
    Package Goods/Cosmetics
    Consumer Discretionary

    $UL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Unilever PLC downgraded by Deutsche Bank

    Deutsche Bank downgraded Unilever PLC from Buy to Hold

    2/9/26 7:00:29 AM ET
    $UL
    Package Goods/Cosmetics
    Consumer Discretionary

    Unilever PLC downgraded by BNP Paribas Exane with a new price target

    BNP Paribas Exane downgraded Unilever PLC from Outperform to Neutral and set a new price target of $71.00

    1/8/26 8:42:50 AM ET
    $UL
    Package Goods/Cosmetics
    Consumer Discretionary

    Morgan Stanley resumed coverage on Unilever PLC with a new price target

    Morgan Stanley resumed coverage of Unilever PLC with a rating of Overweight and set a new price target of $60.10

    12/15/25 10:02:11 AM ET
    $UL
    Package Goods/Cosmetics
    Consumer Discretionary

    $UL
    SEC Filings

    View All

    SEC Form 6-K filed by Unilever PLC

    6-K - UNILEVER PLC (0000217410) (Filer)

    2/5/26 1:46:56 PM ET
    $UL
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form 6-K filed by Unilever PLC

    6-K - UNILEVER PLC (0000217410) (Filer)

    2/3/26 6:42:12 AM ET
    $UL
    Package Goods/Cosmetics
    Consumer Discretionary

    Amendment: SEC Form 6-K/A filed by Unilever PLC

    6-K/A - UNILEVER PLC (0000217410) (Filer)

    1/8/26 7:52:35 AM ET
    $UL
    Package Goods/Cosmetics
    Consumer Discretionary

    $UL
    Financials

    Live finance-specific insights

    View All

    Yellow Wood Partners Completes Acquisition of Elida Beauty from Unilever

    CPG Executive Alfie Vivian Named CEO of Newly Independent CompanyYellow Wood Extends Position as Leading Health and Beauty Investor with Global Brand Portfolio Retail Sales of Over $3 BillionBOSTON, June 6, 2024 /PRNewswire/ -- Yellow Wood Partners LLC ("Yellow Wood"), a Boston-based private equity firm focused on investing in consumer brands and companies, today announced that it has completed the acquisition of Elida Beauty brands from Unilever (NYSE:UL). The Elida Beauty portfolio of storied consumer brands includes Q-tips®, Caress, Ponds and St. Ives (for North America and Europe only), Impulse, Noxzema, Monsavon, and Timotei, among others. The new company has global reach with offices i

    6/6/24 8:19:00 AM ET
    $UL
    Package Goods/Cosmetics
    Consumer Discretionary

    Unilever announces the sale of Suave in North America to Yellow Wood Partners LLC

    Unilever has today announced the sale of its Suave brand in North America to Yellow Wood Partners LLC. The Suave beauty and personal care brand includes hair care, skin care, skin cleansing and deodorant products. Esi Eggleston Bracey, President of Unilever USA and CEO of Unilever Personal Care North America, said, "This is another step on our path to shift our portfolio towards strategic growth spaces. Suave has been a much-loved brand since the 1930s, and I am confident it will continue to thrive and serve consumers under its new ownership in North America." Dana Schmaltz, Partner of Yellow Wood Partners, said, "Suave is ubiquitously recognized for its long history of providing accessib

    2/14/23 9:30:00 AM ET
    $UL
    Package Goods/Cosmetics
    Consumer Discretionary